BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003;125:1651-9. [DOI: 10.1053/j.gastro.2003.09.028] [Cited by in Crossref: 399] [Cited by in F6Publishing: 369] [Article Influence: 22.2] [Reference Citation Analysis]
Number Citing Articles
1 Dunlop SP, Coleman NS, Blackshaw E, Perkins AC, Singh G, Marsden CA, Spiller RC. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005;3:349-357. [PMID: 15822040 DOI: 10.1016/s1542-3565(04)00726-8] [Cited by in Crossref: 222] [Cited by in F6Publishing: 108] [Article Influence: 13.9] [Reference Citation Analysis]
2 Vergnolle N. Postinflammatory visceral sensitivity and pain mechanisms. Neurogastroenterol Motil. 2008;20 Suppl 1:73-80. [PMID: 18402644 DOI: 10.1111/j.1365-2982.2008.01110.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
3 Mearin F, Balboa A. [Post-infectious functional gastrointestinal disorders: from the acute episode to chronicity]. Gastroenterol Hepatol 2011;34:415-21. [PMID: 21641686 DOI: 10.1016/j.gastrohep.2011.03.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Dekel R, Drossman DA, Sperber AD. Abdominal Pain in Irritable Bowel Syndrome (IBS). In: Kapural L, editor. Chronic Abdominal Pain. New York: Springer; 2015. pp. 59-67. [DOI: 10.1007/978-1-4939-1992-5_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Spiller R. Postinfectious Functional Dyspepsia and Postinfectious Irritable Bowel Syndrome: Different Symptoms but Similar Risk Factors. Gastroenterology 2010;138:1660-3. [DOI: 10.1053/j.gastro.2010.03.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
6 El-Salhy M. Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol 2015;21:7621-36. [PMID: 26167065 DOI: 10.3748/wjg.v21.i25.7621] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 38] [Article Influence: 11.2] [Reference Citation Analysis]
7 Drossman DA. Brain imaging and its implications for studying centrally targeted treatments in irritable bowel syndrome: a primer for gastroenterologists. Gut. 2005;54:569-573. [PMID: 15831894 DOI: 10.1136/gut.2004.058446] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
8 Drossman DA. Biopsychosocial Issues in Gastroenterology. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 337-350.e3. [DOI: 10.1016/b978-1-4160-6189-2.00021-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Thabane M, Simunovic M, Akhtar-Danesh N, Garg AX, Clark WF, Collins SM, Salvadori M, Marshall JK. An outbreak of acute bacterial gastroenteritis is associated with an increased incidence of irritable bowel syndrome in children. Am J Gastroenterol. 2010;105:933-939. [PMID: 20179687 DOI: 10.1038/ajg.2010.74] [Cited by in Crossref: 78] [Cited by in F6Publishing: 60] [Article Influence: 7.1] [Reference Citation Analysis]
10 Park JH, Rhee PL, Kim G, Lee JH, Kim YH, Kim JJ, Rhee JC, Song SY. Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome. Neurogastroenterol Motil. 2006;18:539-546. [PMID: 16771769 DOI: 10.1111/j.1365-2982.2006.00771.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 3.9] [Reference Citation Analysis]
11 Limsui D, Pardi DS, Camilleri M, Loftus EV, Kammer PP, Tremaine WJ, Sandborn WJ. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis. 2007;13:175-181. [PMID: 17206699 DOI: 10.1002/ibd.20059] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 6.6] [Reference Citation Analysis]
12 Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol. 2006;101:1288-1294. [PMID: 16771951 DOI: 10.1111/j.1572-0241.2006.00672.x] [Cited by in Crossref: 311] [Cited by in F6Publishing: 298] [Article Influence: 20.7] [Reference Citation Analysis]
13 Tojo R, Suárez A, Clemente MG, de los Reyes-Gavilán CG, Margolles A, Gueimonde M, Ruas-Madiedo P. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol. 2014;20:15163-15176. [PMID: 25386066 DOI: 10.3748/wjg.v20.i41.15163] [Cited by in CrossRef: 229] [Cited by in F6Publishing: 181] [Article Influence: 38.2] [Reference Citation Analysis]
14 Chojnacki C, Błasiak J, Fichna J, Chojnacki J, Popławski T. Evaluation of Melatonin Secretion and Metabolism Exponents in Patients with Ulcerative and Lymphocytic Colitis. Molecules 2018;23:E272. [PMID: 29382152 DOI: 10.3390/molecules23020272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Tuteja AK, Talley NJ, Stoddard GJ, Samore MH, Verne GN. Risk factors for upper and lower functional gastrointestinal disorders in Persian Gulf War Veterans during and post‐deployment. Neurogastroenterology & Motility 2019;31. [DOI: 10.1111/nmo.13533] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Rodríguez-Fandiño OA, Hernández-Ruiz J, López-Vidal Y, Charúa-Guindic L, Escobedo G, Schmulson MJ. Maturation Phenotype of Peripheral Blood Monocyte/Macrophage After Stimulation with Lipopolysaccharides in Irritable Bowel Syndrome. J Neurogastroenterol Motil 2017;23:281-8. [PMID: 28044051 DOI: 10.5056/jnm16137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Shayto RH, Abou Mrad R, Sharara AI. Use of rifaximin in gastrointestinal and liver diseases. World J Gastroenterol 2016;22:6638-51. [PMID: 27547007 DOI: 10.3748/wjg.v22.i29.6638] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
18 von Mentzer B, Murata Y, Ahlstedt I, Lindström E, Martínez V. Functional CRF receptors in BON cells stimulate serotonin release. Biochem Pharmacol. 2007;73:805-813. [PMID: 17184738 DOI: 10.1016/j.bcp.2006.11.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
19 Lee JY, Kim N, Park JH, Nam RH, Lee SM, Song CH, Kim G, Na HY, Choi YJ, Kim JJ, Lee DH. Expression of Neurotrophic Factors, Tight Junction Proteins, and Cytokines According to the Irritable Bowel Syndrome Subtype and Sex. J Neurogastroenterol Motil 2020;26:106-16. [PMID: 31623029 DOI: 10.5056/jnm19099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
20 Ohman L, Isaksson S, Lindmark AC, Posserud I, Stotzer PO, Strid H, Sjövall H, Simrén M. T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol. 2009;104:1205-1212. [PMID: 19367268 DOI: 10.1038/ajg.2009.116] [Cited by in Crossref: 101] [Cited by in F6Publishing: 97] [Article Influence: 8.4] [Reference Citation Analysis]
21 Di Sabatino A, Giuffrida P, Vanoli A, Luinetti O, Manca R, Biancheri P, Bergamaschi G, Alvisi C, Pasini A, Salvatore C. Increase in neuroendocrine cells in the duodenal mucosa of patients with refractory celiac disease. Am J Gastroenterol. 2014;109:258-269. [PMID: 24394748 DOI: 10.1038/ajg.2013.426] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
22 Rhodes DY, Wallace M. Post-infectious irritable bowel syndrome. Curr Gastroenterol Rep. 2006;8:327-332. [PMID: 16836945 DOI: 10.1007/s11894-006-0054-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
23 Camilleri M. Mechanisms in IBS: something old, something new, something borrowed. Neurogastroenterol Motil. 2005;17:311-316. [PMID: 15916617 DOI: 10.1111/j.1365-2982.2004.00632.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
24 Dupont HL. Gastrointestinal infections and the development of irritable bowel syndrome. Curr Opin Infect Dis 2011;24:503-8. [PMID: 21844806 DOI: 10.1097/QCO.0b013e32834a962d] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
25 Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N, Whorwell P; Clinical Services Committee of The British Society of Gastroenterology. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut. 2007;56:1770-1798. [PMID: 17488783 DOI: 10.1136/gut.2007.119446] [Cited by in Crossref: 523] [Cited by in F6Publishing: 408] [Article Influence: 37.4] [Reference Citation Analysis]
26 Spiller RC. Is IBS caused by infectious diarrhea? Nat Clin Pract Gastroenterol Hepatol 2007;4:642-3. [PMID: 17984983 DOI: 10.1038/ncpgasthep0983] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
27 Garsed K, Chernova J, Hastings M, Lam C, Marciani L, Singh G, Henry A, Hall I, Whorwell P, Spiller R. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014;63:1617-1625. [PMID: 24334242 DOI: 10.1136/gutjnl-2013-305989] [Cited by in Crossref: 121] [Cited by in F6Publishing: 96] [Article Influence: 15.1] [Reference Citation Analysis]
28 Bueno L, de Ponti F, Fried M, Kullak-Ublick GA, Kwiatek MA, Pohl D, Quigley EM, Tack J, Talley NJ. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Neurogastroenterol Motil. 2007;19:89-119. [PMID: 17280587 DOI: 10.1111/j.1365-2982.2006.00876.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
29 Barbara G, Stanghellini V, De Giorgio R, Corinaldesi R. Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil. 2006;18:6-17. [PMID: 16371078 DOI: 10.1111/j.1365-2982.2005.00685.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 105] [Article Influence: 8.1] [Reference Citation Analysis]
30 Jung IS, Kim HS, Park H, Lee SI. The clinical course of postinfectious irritable bowel syndrome: a five-year follow-up study. J Clin Gastroenterol. 2009;43:534-540. [PMID: 19262407 DOI: 10.1097/MCG.0b013e31818c87d7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 10] [Article Influence: 3.1] [Reference Citation Analysis]
31 Hale MW, Raison CL, Lowry CA. Integrative physiology of depression and antidepressant drug action: implications for serotonergic mechanisms of action and novel therapeutic strategies for treatment of depression. Pharmacol Ther 2013;137:108-18. [PMID: 23017938 DOI: 10.1016/j.pharmthera.2012.09.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
32 Ruigómez A, García Rodríguez LA, Panés J. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities. Clin Gastroenterol Hepatol 2007;5:465-9. [PMID: 17445753 DOI: 10.1016/j.cgh.2007.02.008] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
33 Berumen A, Edwinson AL, Grover M. Post-infection Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:445-61. [PMID: 34024451 DOI: 10.1016/j.gtc.2021.02.007] [Reference Citation Analysis]
34 de Saussure PP. Management of the returning traveler with diarrhea. Therap Adv Gastroenterol 2009;2:367-75. [PMID: 21180583 DOI: 10.1177/1756283X09346668] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
35 Zhou FL, Zhang WG, Wei YC, Xu KL, Hui LY, Wang XS, Li MZ. Impact of comorbid anxiety and depression on quality of life and cellular immunity changes in patients with digestive tract cancers. World J Gastroenterol 2005;11:2313-8. [PMID: 15818744 DOI: 10.3748/wjg.v11.i15.2313] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
36 Chang L, Adeyemo M, Karagiannides I, Videlock EJ, Bowe C, Shih W, Presson AP, Yuan PQ, Cortina G, Gong H. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol. 2012;107:262-272. [PMID: 22158028 DOI: 10.1038/ajg.2011.423] [Cited by in Crossref: 98] [Cited by in F6Publishing: 87] [Article Influence: 9.8] [Reference Citation Analysis]
37 Moran GW, Leslie FC, Levison SE, Worthington J, McLaughlin JT. Enteroendocrine cells: neglected players in gastrointestinal disorders? Therap Adv Gastroenterol. 2008;1:51-60. [PMID: 21180514 DOI: 10.1177/1756283x08093943] [Cited by in Crossref: 58] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
38 Hellström PM. Pathophysiology of the irritable bowel syndrome - Reflections of today. Best Pract Res Clin Gastroenterol 2019;40-41:101620. [PMID: 31594651 DOI: 10.1016/j.bpg.2019.05.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
39 Thabane M, Simunovic M, Akhtar-Danesh N, Marshall JK. Development and validation of a risk score for post-infectious irritable bowel syndrome. Am J Gastroenterol 2009;104:2267-74. [PMID: 19568228 DOI: 10.1038/ajg.2009.302] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
40 Pogreba-brown K, Austhof E, Armstrong A, Schaefer K, Villa Zapata L, Mcclelland DJ, Batz MB, Kuecken M, Riddle M, Porter CK, Bazaco MC. Chronic Gastrointestinal and Joint-Related Sequelae Associated with Common Foodborne Illnesses: A Scoping Review. Foodborne Pathogens and Disease 2020;17:67-86. [DOI: 10.1089/fpd.2019.2692] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
41 Kerckhoffs AP, ter Linde JJ, Akkermans LM, Samsom M. SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine. Am J Physiol Gastrointest Liver Physiol. 2012;302:G1053-G1060. [PMID: 22323131 DOI: 10.1152/ajpgi.00153.2011] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
42 Hu X, Zhang X, Han B, Bei W. The inhibitory effect of tongxieyaofang on rats with post infectious irritable bowel syndrome through regulating colonic par-2 receptor. BMC Complement Altern Med. 2013;13:246. [PMID: 24088410 DOI: 10.1186/1472-6882-13-246] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
43 Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol 2010;105:652-61. [PMID: 19861955 DOI: 10.1038/ajg.2009.621] [Cited by in Crossref: 93] [Cited by in F6Publishing: 58] [Article Influence: 7.8] [Reference Citation Analysis]
44 Piche T. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation? Neurogastroenterol Motil. 2014;26:296-302. [PMID: 24548256 DOI: 10.1111/nmo.12315] [Cited by in Crossref: 85] [Cited by in F6Publishing: 69] [Article Influence: 12.1] [Reference Citation Analysis]
45 Quigley EM. Microflora modulation of motility. J Neurogastroenterol Motil. 2011;17:140-147. [PMID: 21602990 DOI: 10.5056/jnm.2011.17.2.140] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 7.1] [Reference Citation Analysis]
46 Painsipp E, Wultsch T, Shahbazian A, Edelsbrunner M, Kreissl MC, Schirbel A, Bock E, Pabst MA, Thoeringer CK, Huber HP, Holzer P. Experimental gastritis in mice enhances anxiety in a gender-related manner. Neuroscience 2007;150:522-36. [PMID: 17945426 DOI: 10.1016/j.neuroscience.2007.09.024] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
47 Ohman L, Lindmark AC, Isaksson S, Posserud I, Strid H, Sjövall H, Simrén M. B-cell activation in patients with irritable bowel syndrome (IBS). Neurogastroenterol Motil. 2009;21:644-650, e27. [PMID: 19222763 DOI: 10.1111/j.1365-2982.2009.01272.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
48 Dunlop SP, Jenkins D, Spiller RC. Age-related decline in rectal mucosal lymphocytes and mast cells: . European Journal of Gastroenterology & Hepatology 2004;16:1011-5. [DOI: 10.1097/00042737-200410000-00010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
49 Buhner S, Li Q, Berger T, Vignali S, Barbara G, De Giorgio R, Stanghellini V, Schemann M. Submucous rather than myenteric neurons are activated by mucosal biopsy supernatants from irritable bowel syndrome patients. Neurogastroenterol Motil. 2012;24:e1134-e1572. [PMID: 22963673 DOI: 10.1111/nmo.12011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
50 Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377-1390. [PMID: 16678553 DOI: 10.1053/j.gastro.2006.03.008] [Cited by in Crossref: 1337] [Cited by in F6Publishing: 999] [Article Influence: 89.1] [Reference Citation Analysis]
51 Lane RD, Waldstein SR, Critchley HD, Derbyshire SW, Drossman DA, Wager TD, Schneiderman N, Chesney MA, Jennings JR, Lovallo WR, Rose RM, Thayer JF, Cameron OG. The rebirth of neuroscience in psychosomatic medicine, Part II: clinical applications and implications for research. Psychosom Med 2009;71:135-51. [PMID: 19196806 DOI: 10.1097/PSY.0b013e318198a11f] [Cited by in Crossref: 55] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
52 McLaughlin J, Houghton LA. The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome. Expert Opin Drug Saf. 2006;5:313-327. [PMID: 16503751 DOI: 10.1517/14740338.5.2.313] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
53 Wheatcroft J, Wakelin D, Smith A, Mahoney CR, Mawe G, Spiller R. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil. 2005;17:863-870. [PMID: 16336502 DOI: 10.1111/j.1365-2982.2005.00719.x] [Cited by in Crossref: 143] [Cited by in F6Publishing: 131] [Article Influence: 9.5] [Reference Citation Analysis]
54 Esan OB, Pearce M, van Hecke O, Roberts N, Collins DRJ, Violato M, McCarthy N, Perera R, Fanshawe TR. Factors Associated with Sequelae of Campylobacter and Non-typhoidal Salmonella Infections: A Systematic Review. EBioMedicine 2017;15:100-11. [PMID: 27965105 DOI: 10.1016/j.ebiom.2016.12.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
55 Qin HY, Xavier Wong HL, Zang KH, Li X, Bian ZX. Enterochromaffin cell hyperplasia in the gut: Factors, mechanism and therapeutic clues. Life Sci 2019;239:116886. [PMID: 31678286 DOI: 10.1016/j.lfs.2019.116886] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
56 Nylund CM, Denson LA, Noel JM. Bacterial enteritis as a risk factor for childhood intussusception: a retrospective cohort study. J Pediatr 2010;156:761-5. [PMID: 20138300 DOI: 10.1016/j.jpeds.2009.11.026] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
57 El-Salhy M, Gilja OH, Hatlebakk JG, Hausken T. Stomach antral endocrine cells in patients with irritable bowel syndrome. Int J Mol Med. 2014;34:967-974. [PMID: 25110039 DOI: 10.3892/ijmm.2014.1887] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
58 Wouters MM, Vicario M, Santos J. The role of mast cells in functional GI disorders. Gut. 2016;65:155-168. [PMID: 26194403 DOI: 10.1136/gutjnl-2015-309151] [Cited by in Crossref: 147] [Cited by in F6Publishing: 133] [Article Influence: 24.5] [Reference Citation Analysis]
59 Kim DH, Cho YJ, Kim JH, Kim YB, Lee KJ. Stress-induced alterations in mast cell numbers and proteinase-activated receptor-2 expression of the colon: role of corticotrophin-releasing factor. J Korean Med Sci. 2010;25:1330-1335. [PMID: 20808677 DOI: 10.3346/jkms.2010.25.9.1330] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
60 Eutamene H, Lamine F, Chabo C, Theodorou V, Rochat F, Bergonzelli GE, Corthésy-Theulaz I, Fioramonti J, Bueno L. Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats. J Nutr 2007;137:1901-7. [PMID: 17634262 DOI: 10.1093/jn/137.8.1901] [Cited by in Crossref: 95] [Cited by in F6Publishing: 95] [Article Influence: 6.8] [Reference Citation Analysis]
61 Mearin F, Perelló A, Balboa A, Perona M, Sans M, Salas A, Angulo S, Lloreta J, Benasayag R, García-gonzalez MA, Pérez-oliveras M, Coderch J. Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: Results 3 years after gastroenteritis. Scandinavian Journal of Gastroenterology 2009;44:1173-85. [DOI: 10.1080/00365520903171276] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
62 Käll E, Lindström E, Martinez V. The serotonin reuptake inhibitor citalopram does not affect colonic sensitivity or compliance in rats. European Journal of Pharmacology 2007;570:203-11. [DOI: 10.1016/j.ejphar.2007.05.032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
63 Camilleri M, Halawi H, Oduyebo I. Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we? Expert Rev Gastroenterol Hepatol 2017;11:303-16. [PMID: 28128666 DOI: 10.1080/17474124.2017.1288096] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
64 Sidhu R, Drew K, McAlindon ME, Lobo AJ, Sanders DS. Elevated serum chromogranin A in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): a shared model for pathogenesis? Inflamm Bowel Dis. 2010;16:361. [PMID: 19575362 DOI: 10.1002/ibd.20982] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
65 Farmer AD, Wood E, Ruffle JK. An approach to the care of patients with irritable bowel syndrome. CMAJ 2020;192:E275-82. [PMID: 32179536 DOI: 10.1503/cmaj.190716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Saha L, Malhotra S, Rana S, Bhasin D, Pandhi P. A preliminary study of melatonin in irritable bowel syndrome. J Clin Gastroenterol. 2007;41:29-32. [PMID: 17198061 DOI: 10.1097/mcg.0b013e31802df84c] [Cited by in Crossref: 44] [Cited by in F6Publishing: 10] [Article Influence: 3.1] [Reference Citation Analysis]
67 Bian ZX, Zhang M, Han QB, Xu HX, Sung JJ. Analgesic effects of JCM-16021 on neonatal maternal separation-induced visceral pain in rats. World J Gastroenterol. 2010;16:837-845. [PMID: 20143462 DOI: 10.3748/wjg.v16.i7.837] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
68 Ramiah Rajasekaran P, Chapin AA, Quan DN, Herberholz J, Bentley WE, Ghodssi R. 3D-Printed electrochemical sensor-integrated transwell systems. Microsyst Nanoeng 2020;6:100. [PMID: 34567709 DOI: 10.1038/s41378-020-00208-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
69 Tanaka Y, Kanazawa M, Fukudo S, Drossman DA. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:131-139. [PMID: 21602989 DOI: 10.5056/jnm.2011.17.2.13] [Reference Citation Analysis]
70 El-Salhy M. Recent advances in the diagnosis of irritable bowel syndrome. Expert Rev Gastroenterol Hepatol 2015;9:1161-74. [PMID: 26162959 DOI: 10.1586/17474124.2015.1067138] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
71 Powell N, Walker MM, Talley NJ. The mucosal immune system: master regulator of bidirectional gut–brain communications. Nat Rev Gastroenterol Hepatol 2017;14:143-59. [DOI: 10.1038/nrgastro.2016.191] [Cited by in Crossref: 142] [Cited by in F6Publishing: 112] [Article Influence: 35.5] [Reference Citation Analysis]
72 Gulcan E, Taser F, Toker A, Korkmaz U, Alcelik A. Increased frequency of prediabetes in patients with irritable bowel syndrome. Am J Med Sci. 2009;338:116-119. [PMID: 19561452 DOI: 10.1097/MAJ.0b013e31819f7587] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
73 Kilkens TO, Honig A, Maes M, Lousberg R, Brummer RJ. Fatty acid profile and affective dysregulation in irritable bowel syndrome. Lipids 2004;39:425-31. [PMID: 15506237 DOI: 10.1007/s11745-004-1247-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
74 Quigley EM. Editorial: PARs for the Course: Roles of Proteases and PAR Receptors in Subtly Inflamed Irritable Bowel Syndrome: . American Journal of Gastroenterology 2013;108:1644-6. [DOI: 10.1038/ajg.2013.245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
75 Vivinus-nébot M, Dainese R, Anty R, Saint-paul MC, Nano JL, Gonthier N, Marjoux S, Frin-mathy G, Bernard G, Hébuterne X, Tran A, Theodorou V, Piche T. Combination of Allergic Factors Can Worsen Diarrheic Irritable Bowel Syndrome: Role of Barrier Defects and Mast Cells. American Journal of Gastroenterology 2012;107:75-81. [DOI: 10.1038/ajg.2011.315] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 9.7] [Reference Citation Analysis]
76 Sarna SK. Lessons Learnt from Post-Infectious IBS. Front Physiol. 2011;2:49. [PMID: 21897820 DOI: 10.2289/fphys.2011.00049.epub] [Reference Citation Analysis]
77 Mawe GM, Coates MD, Moses PL. Review article: intestinal serotonin signalling in irritable bowel syndrome. Aliment Pharmacol Ther. 2006;23:1067-1076. [PMID: 16611266 DOI: 10.1111/j.1365-2036.2006.02858.x] [Cited by in Crossref: 136] [Cited by in F6Publishing: 130] [Article Influence: 9.1] [Reference Citation Analysis]
78 Schoepfer AM, Schaffer T, Seibold-Schmid B, Müller S, Seibold F. Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterol Motil. 2008;20:1110-1118. [PMID: 18694443 DOI: 10.1111/j.1365-2982.2008.01166.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 5.3] [Reference Citation Analysis]
79 Beatty JK, Bhargava A, Buret AG. Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection. World J Gastroenterol. 2014;20:3976-3985. [PMID: 24744587 DOI: 10.3748/wjg.v20.i14.3976] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 41] [Article Influence: 9.0] [Reference Citation Analysis]
80 Klem F, Wadhwa A, Prokop LJ, Sundt WJ, Farrugia G, Camilleri M, Singh S, Grover M. Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis. Gastroenterology. 2017;152:1042-1054.e1. [PMID: 28069350 DOI: 10.1053/j.gastro.2016.12.039] [Cited by in Crossref: 146] [Cited by in F6Publishing: 116] [Article Influence: 36.5] [Reference Citation Analysis]
81 Lee YT, Hu LY, Shen CC, Huang MW, Tsai SJ, Yang AC, Hu CK, Perng CL, Huang YS, Hung JH. Risk of Psychiatric Disorders following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study. PLoS One. 2015;10:e0133283. [PMID: 26222511 DOI: 10.1371/journal.pone.0133283] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
82 Lam C, Tan W, Leighton M, Hastings M, Lingaya M, Falcone Y, Zhou X, Xu L, Whorwell P, Walls AF, Zaitoun A, Montgomery A, Spiller RC. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): a multicentre, parallel-group, randomised placebo-controlled trial. Efficacy Mech Eval 2015;2:1-62. [DOI: 10.3310/eme02020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
83 Dinan TG, Quigley EM, Ahmed SM, Scully P, O'Brien S, O'Mahony L, O'Mahony S, Shanahan F, Keeling PW. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology. 2006;130:304-311. [PMID: 16472586 DOI: 10.1053/j.gastro.2005.11.033] [Cited by in Crossref: 407] [Cited by in F6Publishing: 379] [Article Influence: 27.1] [Reference Citation Analysis]
84 Rabbi MF, Labis B, Metz-Boutigue MH, Bernstein CN, Ghia JE. Catestatin decreases macrophage function in two mouse models of experimental colitis. Biochem Pharmacol 2014;89:386-98. [PMID: 24637240 DOI: 10.1016/j.bcp.2014.03.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
85 Schwille-Kiuntke J, Enck P, Zendler C, Krieg M, Polster AV, Klosterhalfen S, Autenrieth IB, Zipfel S, Frick JS. Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter. Neurogastroenterol Motil. 2011;23:e479-e488. [PMID: 21883703 DOI: 10.1111/j.1365-2982.2011.01779.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 52] [Article Influence: 6.7] [Reference Citation Analysis]
86 Spiller R. Serotonin and GI clinical disorders. Neuropharmacology. 2008;55:1072-1080. [PMID: 18687345 DOI: 10.1016/j.neuropharm.2008.07.016] [Cited by in Crossref: 155] [Cited by in F6Publishing: 142] [Article Influence: 11.9] [Reference Citation Analysis]
87 Schiller LR, Sellin JH. Diarrhea. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 211-232.e4. [DOI: 10.1016/b978-1-4160-6189-2.00015-9] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
88 Grenham S, Clarke G, Cryan JF, Dinan TG. Brain-gut-microbe communication in health and disease. Front Physiol. 2011;2:94. [PMID: 22162969 DOI: 10.3389/fphys.2011.00094] [Cited by in Crossref: 425] [Cited by in F6Publishing: 363] [Article Influence: 42.5] [Reference Citation Analysis]
89 Costedio MM, Hyman N, Mawe GM. Serotonin and its role in colonic function and in gastrointestinal disorders. Dis Colon Rectum. 2007;50:376-388. [PMID: 17195902 DOI: 10.1007/s10350-006-0763-3] [Cited by in Crossref: 111] [Cited by in F6Publishing: 97] [Article Influence: 7.9] [Reference Citation Analysis]
90 Kennedy PJ, Clarke G, Quigley EM, Groeger JA, Dinan TG, Cryan JF. Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci Biobehav Rev. 2012;36:310-340. [PMID: 21777613 DOI: 10.1016/j.neubiorev.2011.07.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 10.3] [Reference Citation Analysis]
91 Kanazawa M, Fukudo S. Relationship between infectious gastroenteritis and irritable bowel syndrome. Clin J Gastroenterol. 2014;7:14-18. [PMID: 26183503 DOI: 10.1007/s12328-013-0444-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
92 Takakura W, Pimentel M. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome - An Update. Front Psychiatry. 2020;11:664. [PMID: 32754068 DOI: 10.3389/fpsyt.2020.00664] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
93 Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol. 2007;42 Suppl 17:41-47. [PMID: 17238025 DOI: 10.1007/s00535-006-1925-8] [Cited by in Crossref: 122] [Cited by in F6Publishing: 108] [Article Influence: 8.7] [Reference Citation Analysis]
94 Wong HLX, Qin HY, Tsang SW, Zuo X, Che S, Chow CFW, Li X, Xiao HT, Zhao L, Huang T, Lin CY, Kwan HY, Yang T, Longo FM, Lyu A, Bian ZX. Early life stress disrupts intestinal homeostasis via NGF-TrkA signaling. Nat Commun 2019;10:1745. [PMID: 30988299 DOI: 10.1038/s41467-019-09744-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
95 Törnblom H, Abrahamsson H, Barbara G, Hellström PM, Lindberg G, Nyhlin H, Ohlsson B, Simrèn M, Sjölund K, Sjövall H, Schmidt PT, Öhman L, Group TSM. Inflammation as a cause of functional bowel disorders. Scandinavian Journal of Gastroenterology 2005;40:1140-8. [DOI: 10.1080/00365520510023657] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
96 Spiller R, Lam C. An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil. 2012;18:258-268. [PMID: 22837873 DOI: 10.5056/jnm.2012. 18.3.258] [Reference Citation Analysis]
97 Aerssens J, Hillsley K, Peeters PJ, de Hoogt R, Stanisz A, Lin JH, Van den Wyngaert I, Göhlmann HW, Grundy D, Stead RH, Coulie B. Alterations in the brain-gut axis underlying visceral chemosensitivity in Nippostrongylus brasiliensis-infected mice. Gastroenterology 2007;132:1375-87. [PMID: 17408648 DOI: 10.1053/j.gastro.2007.02.019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
98 Lin L, Feng B, Zhou R, Liu Y, Li L, Wang K, Yu Y, Liu C, Long X, Gu X, Li B, Wang X, Yang X, Cong Y, Zuo X, Li Y. Acute stress disrupts intestinal homeostasis via GDNF-RET. Cell Prolif 2020;53:e12889. [PMID: 32808420 DOI: 10.1111/cpr.12889] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Hughes PA, Brierley SM, Blackshaw LA. Post-inflammatory modification of colonic afferent mechanosensitivity. Clin Exp Pharmacol Physiol. 2009;36:1034-1040. [PMID: 19566823 DOI: 10.1111/j.1440-1681.2009.05248.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
100 Farmer AD, Aziz Q. Mechanisms of visceral pain in health and functional gastrointestinal disorders. Scand J Pain 2014;5:51-60. [PMID: 29913680 DOI: 10.1016/j.sjpain.2014.01.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
101 Mondelaers SU, Theofanous SA, Florens MV, Perna E, Aguilera-Lizarraga J, Boeckxstaens GE, Wouters MM. Effect of genetic background and postinfectious stress on visceral sensitivity in Citrobacter rodentium-infected mice. Neurogastroenterol Motil 2016;28:647-58. [PMID: 26728091 DOI: 10.1111/nmo.12759] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
102 Qin HY, Xiao HT, Leung FP, Yang ZJ, Wu JC, Sung JJ, Xu HX, Tong XD, Bian ZX. JCM-16021, a Chinese herbal formula, attenuated visceral hyperalgesia in TNBS-induced postinflammatory irritable bowel syndrome through reducing colonic EC cell hyperplasia and serotonin availability in rats. Evid Based Complement Alternat Med. 2012;2012:239638. [PMID: 22719782 DOI: 10.1155/2012/239638] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
103 Sweileh WM, Al-Jabi SW, Sawalha AF, AbuTaha AS, Zyoud SH. Bibliometric analysis of publications on Campylobacter: (2000-2015). J Health Popul Nutr 2016;35:39. [PMID: 27899145 DOI: 10.1186/s41043-016-0076-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
104 Yu DC, Bury JP, Tiernan J, Waby JS, Staton CA, Corfe BM. Short-chain fatty acid level and field cancerization show opposing associations with enteroendocrine cell number and neuropilin expression in patients with colorectal adenoma. Mol Cancer 2011;10:27. [PMID: 21401950 DOI: 10.1186/1476-4598-10-27] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
105 Hisamatsu T, Inoue N, Yajima T, Izumiya M, Ichikawa H, Hibi T. Psychological aspects of inflammatory bowel disease. J Gastroenterol. 2007;42 Suppl 17:34-40. [PMID: 17238024 DOI: 10.1007/s00535-006-1937-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
106 Dlugosz A, Törnblom H, Mohammadian G, Morgan G, Veress B, Edvinsson B, Sandström G, Lindberg G. Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome. BMC Gastroenterol 2010;10:19. [PMID: 20158890 DOI: 10.1186/1471-230X-10-19] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
107 Ringel Y, Maharshak N. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2013;305:G529-G541. [PMID: 23886861 DOI: 10.1152/ajpgi.00207.2012] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 8.5] [Reference Citation Analysis]
108 Riddle MS, Gutierrez RL, Verdu EF, Porter CK. The chronic gastrointestinal consequences associated with campylobacter. Curr Gastroenterol Rep. 2012;14:395-405. [PMID: 22864805 DOI: 10.1007/s11894-012-0278-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
109 Cremon C, Carini G, Wang B, Vasina V, Cogliandro RF, De Giorgio R, Stanghellini V, Grundy D, Tonini M, De Ponti F. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. Am J Gastroenterol. 2011;106:1290-1298. [PMID: 21427712 DOI: 10.1038/ajg.2011.86] [Cited by in Crossref: 125] [Cited by in F6Publishing: 122] [Article Influence: 12.5] [Reference Citation Analysis]
110 Ghoshal UC, Rahman MM. Post-infection irritable bowel syndrome in the tropical and subtropical regions: Vibrio cholerae is a new cause of this well-known condition. Indian J Gastroenterol. 2019;38:87-94. [PMID: 31073702 DOI: 10.1007/s12664-019-00959-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
111 Wouters MM, Van Wanrooy S, Nguyen A, Dooley J, Aguilera-Lizarraga J, Van Brabant W, Garcia-Perez JE, Van Oudenhove L, Van Ranst M, Verhaegen J, Liston A, Boeckxstaens G. Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis. Gut. 2016;65:1279-1288. [PMID: 26071133 DOI: 10.1136/gutjnl-2015-309460] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
112 Öhman L, Törnblom H, Simrén M. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nat Rev Gastroenterol Hepatol 2015;12:36-49. [DOI: 10.1038/nrgastro.2014.200] [Cited by in Crossref: 106] [Cited by in F6Publishing: 94] [Article Influence: 15.1] [Reference Citation Analysis]
113 Dizdar V, Gilja OH, Hausken T. Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron. Neurogastroenterol Motil. 2007;19:977-982. [PMID: 17973637 DOI: 10.1111/j.1365-2982.2007.00988.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 31] [Article Influence: 1.0] [Reference Citation Analysis]
114 Chang L, Sundaresh S, Elliott J, Anton PA, Baldi P, Licudine A, Mayer M, Vuong T, Hirano M, Naliboff BD. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil. 2009;21:149-159. [PMID: 18684212 DOI: 10.1111/j.1365-2982.2008.01171.x] [Cited by in Crossref: 153] [Cited by in F6Publishing: 148] [Article Influence: 11.8] [Reference Citation Analysis]
115 Taché Y, Brunnhuber S. From Hans Selye's discovery of biological stress to the identification of corticotropin-releasing factor signaling pathways: implication in stress-related functional bowel diseases. Ann N Y Acad Sci. 2008;1148:29-41. [PMID: 19120089 DOI: 10.1196/annals.1410.007] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
116 El-Salhy M. Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol. 2012;18:5151-5163. [PMID: 23066308 DOI: 10.3748/wjg.v18.i37.5151] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 90] [Article Influence: 7.9] [Reference Citation Analysis]
117 Ahn JY, Lee KH, Choi CH, Kim JW, Lee HW, Kim JW, Kim MK, Kwon GY, Han S, Kim SE. Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis. Dig Dis Sci. 2014;59:1001-1011. [PMID: 24282051 DOI: 10.1007/s10620-013-2930-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
118 Svendsen AT, Bytzer P, Engsbro AL. Systematic review with meta-analyses: does the pathogen matter in post-infectious irritable bowel syndrome? Scand J Gastroenterol 2019;54:546-62. [PMID: 31112663 DOI: 10.1080/00365521.2019.1607897] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
119 Schwille-Kiuntke J, Mazurak N, Enck P. Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers' diarrhoea. Aliment Pharmacol Ther 2015;41:1029-37. [PMID: 25871571 DOI: 10.1111/apt.13199] [Cited by in Crossref: 66] [Cited by in F6Publishing: 47] [Article Influence: 11.0] [Reference Citation Analysis]
120 Róka R, Rosztóczy A, Leveque M, Izbéki F, Nagy F, Molnár T, Lonovics J, Garcia-Villar R, Fioramonti J, Wittmann T. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2007;5:550-555. [PMID: 17336590 DOI: 10.1016/j.cgh.2006.12.004] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 6.3] [Reference Citation Analysis]
121 Törnblom H, Holmvall P, Svenungsson B, Lindberg G. Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults. Clin Gastroenterol Hepatol 2007;5:461-4. [PMID: 17445752 DOI: 10.1016/j.cgh.2007.01.007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
122 Spiller R, Garsed K. Infection, inflammation, and the irritable bowel syndrome. Dig Liver Dis. 2009;41:844-849. [PMID: 19716778 DOI: 10.1016/j.dld.2009.07.007] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 6.8] [Reference Citation Analysis]
123 Ihekweazu FD, Versalovic J. Development of the Pediatric Gut Microbiome: Impact on Health and Disease. Am J Med Sci 2018;356:413-23. [PMID: 30384950 DOI: 10.1016/j.amjms.2018.08.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 9.7] [Reference Citation Analysis]
124 Taché Y, Million M, Nelson AG, Lamy C, Wang L. Role of corticotropin-releasing factor pathways in stress-related alterations of colonic motor function and viscerosensibility in female rodents. Gend Med. 2005;2:146-154. [PMID: 16290887 DOI: 10.1016/s1550-8579(05)80043-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
125 El-Salhy M, Gundersen D, Ostgaard H, Lomholt-Beck B, Hatlebakk JG, Hausken T. Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome. Dig Dis Sci. 2012;57:873-878. [PMID: 22057239 DOI: 10.1007/s10620-011-1948-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
126 O’malley D, Quigley EM, Dinan TG, Cryan JF. Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome? Brain, Behavior, and Immunity 2011;25:1333-41. [DOI: 10.1016/j.bbi.2011.04.009] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 7.5] [Reference Citation Analysis]
127 Connor BA, Riddle MS. Post-infectious sequelae of travelers' diarrhea. J Travel Med 2013;20:303-12. [PMID: 23992573 DOI: 10.1111/jtm.12049] [Cited by in Crossref: 58] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
128 Grider JR. Desensitization of the peristaltic reflex induced by mucosal stimulation with the selective 5-HT 4 agonist tegaserod. American Journal of Physiology-Gastrointestinal and Liver Physiology 2006;290:G319-27. [DOI: 10.1152/ajpgi.00326.2005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
129 Ohman L, Stridsberg M, Isaksson S, Jerlstad P, Simrén M. Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms? Am J Gastroenterol. 2012;107:440-447. [PMID: 22233694 DOI: 10.1038/ajg.2011.458] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
130 Coleman NS, Foley S, Dunlop SP, Wheatcroft J, Blackshaw E, Perkins AC, Singh G, Marsden CA, Holmes GK, Spiller RC. Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease. Clin Gastroenterol Hepatol. 2006;4:874-881. [PMID: 16797248 DOI: 10.1016/j.cgh.2006.04.017] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 4.5] [Reference Citation Analysis]
131 Goodwin RD, Cowles RA, Galea S, Jacobi F. Gastritis and mental disorders. J Psychiatr Res. 2013;47:128-132. [PMID: 23073472 DOI: 10.1016/j.jpsychires.2012.09.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
132 Taché Y, Martinez V, Wang L, Million M. CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome. Br J Pharmacol. 2004;141:1321-1330. [PMID: 15100165 DOI: 10.1038/sj.bjp.0705760] [Cited by in Crossref: 169] [Cited by in F6Publishing: 157] [Article Influence: 9.9] [Reference Citation Analysis]
133 De Giorgio R, Barbara G. Is irritable bowel syndrome an inflammatory disorder? Curr Gastroenterol Rep. 2008;10:385-390. [PMID: 18627650 DOI: 10.1007/s11894-008-0073-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
134 Scalera A, Di Minno MN, Tarantino G. What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol. 2013;19:5402-5420. [PMID: 24023483 DOI: 10.3748/wjg.v19.i33.5402] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
135 Ochoa-Cortes F, Guerrero-Alba R, Valdez-Morales EE, Spreadbury I, Barajas-Lopez C, Castro M, Bertrand J, Cenac N, Vergnolle N, Vanner SJ. Chronic stress mediators act synergistically on colonic nociceptive mouse dorsal root ganglia neurons to increase excitability. Neurogastroenterol Motil. 2014;26:334-345. [PMID: 24286174 DOI: 10.1111/nmo.12268] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
136 Rusu F, Mocanu L, Dumitraşcu DL. Phenotypic features of patients with post-infectious irritable bowel syndrome. Med Pharm Rep 2019;92:239-45. [PMID: 31460504 DOI: 10.15386/mpr-1317] [Reference Citation Analysis]
137 Tort S, Balboa A, Marzo M, Carrillo R, Mínguez M, Valdepérez J, Alonso-Coello P, Mascort JJ, Ferrándiz J, Bonfill X, Piqué JM, Mearin F; Centro Cochrame Iberoamericano., Asociación Española de Gastroentología., Sociedad Española de Medicina de Familia y Comunitaria (SEMFYC). [Clinical practice guideline for irritable bowel syndrome]. Gastroenterol Hepatol 2006;29:467-521. [PMID: 17020681 DOI: 10.1157/13092567] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
138 Srivastava D, Ghoshal U, Mittal RD, Ghoshal UC. Associations between IL-1RA polymorphisms and small intestinal bacterial overgrowth among patients with irritable bowel syndrome from India. Neurogastroenterol Motil. 2014;26:1408-1416. [PMID: 25073651 DOI: 10.1111/nmo.12399] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
139 Macsharry J, O'Mahony L, Fanning A, Bairead E, Sherlock G, Tiesman J, Fulmer A, Kiely B, Dinan TG, Shanahan F, Quigley EM. Mucosal cytokine imbalance in irritable bowel syndrome. Scand J Gastroenterol. 2008;43:1467-1476. [PMID: 18752146 DOI: 10.1080/00365520802276127] [Cited by in Crossref: 103] [Cited by in F6Publishing: 106] [Article Influence: 8.6] [Reference Citation Analysis]
140 Laing ST, Merriam D, Shock BC, Mills S, Spinner A, Reader R, Hartigan-O'Connor DJ. Idiopathic Colitis in Rhesus Macaques Is Associated With Dysbiosis, Abundant Enterochromaffin Cells and Altered T-Cell Cytokine Expression. Vet Pathol 2018;55:741-52. [PMID: 29929446 DOI: 10.1177/0300985818780449] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
141 Shen B, Liu W, Remzi FH, Shao Z, Lu H, DeLaMotte C, Hammel J, Queener E, Bambrick ML, Fazio VW. Enterochromaffin cell hyperplasia in irritable pouch syndrome. Am J Gastroenterol. 2008;103:2293-2300. [PMID: 18702649 DOI: 10.1111/j.1572-0241.2008.01990.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
142 Spiller RC. Irritable bowel syndrome: Bacteria and inflammation—Clinical relevance now. Curr Treat Options Gastro 2007;10:312-21. [DOI: 10.1007/s11938-007-0074-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
143 Spiller R, Major G. IBS and IBD - separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol. 2016;13:613-621. [PMID: 27667579 DOI: 10.1038/nrgastro.2016.141] [Cited by in Crossref: 70] [Cited by in F6Publishing: 55] [Article Influence: 17.5] [Reference Citation Analysis]
144 Wang C, Fang X. Inflammation and Overlap of Irritable Bowel Syndrome and Functional Dyspepsia. J Neurogastroenterol Motil 2021;27:153-64. [PMID: 33795538 DOI: 10.5056/jnm20175] [Reference Citation Analysis]
145 Piche T, Ducrotté P, Sabate JM, Coffin B, Zerbib F, Dapoigny M, Hua M, Marine-Barjoan E, Dainese R, Hébuterne X. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome. Neurogastroenterol Motil. 2010;22:626-e174. [PMID: 20403099 DOI: 10.1111/j.1365-2982.2010.01502.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 5.2] [Reference Citation Analysis]
146 Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol. 2013;29:79-84. [PMID: 23041678 DOI: 10.1097/mog.0b013e32835a4b3e] [Cited by in Crossref: 201] [Cited by in F6Publishing: 105] [Article Influence: 25.1] [Reference Citation Analysis]
147 Adam B, Liebregts T, Gschossmann JM, Krippner C, Scholl F, Ruwe M, Holtmann G. Severity of mucosal inflammation as a predictor for alterations of visceral sensory function in a rat model. Pain. 2006;123:179-186. [PMID: 16630696 DOI: 10.1016/j.pain.2006.02.029] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 4.7] [Reference Citation Analysis]
148 Walker MM, Talley NJ. Functional gastrointestinal disorders and the potential role of eosinophils. Gastroenterol Clin North Am. 2008;37:383-395, vi. [PMID: 18499026 DOI: 10.1016/j.gtc.2008.02.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
149 Marshall JK, Thabane M, Borgaonkar MR, James C. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol. 2007;5:457-460. [PMID: 17289440 DOI: 10.1016/j.cgh.2006.11.025] [Cited by in Crossref: 153] [Cited by in F6Publishing: 122] [Article Influence: 10.9] [Reference Citation Analysis]
150 Creed F. Cognitive behavioural model of irritable bowel syndrome. Gut 2007;56:1039-41. [PMID: 17625139 DOI: 10.1136/gut.2006.117143] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
151 Plavšić I, Hauser G, Tkalčić M, Pletikosić S, Salkić N. Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers. Gastroenterol Res Pract. 2015;2015:490183. [PMID: 26170833 DOI: 10.1155/2015/490183] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
152 Barbara G, Cremon C, Carini G, Bellacosa L, Zecchi L, De Giorgio R, Corinaldesi R, Stanghellini V. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:349-359. [PMID: 22148103 DOI: 10.5056/jnm.2011.17.4.349] [Cited by in Crossref: 119] [Cited by in F6Publishing: 101] [Article Influence: 11.9] [Reference Citation Analysis]
153 Halpert A, Drossman D. Biopsychosocial issues in irritable bowel syndrome. J Clin Gastroenterol. 2005;39:665-669. [PMID: 16082273 DOI: 10.1097/01.mcg.0000174024.81096.44] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
154 Connor BA. Sequelae of traveler’s diarrhea: focus on postinfectious irritable bowel syndrome. Clin Infect Dis. 2005;41 Suppl 8:S577-S586. [PMID: 16267722 DOI: 10.1086/432956] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
155 Schmulson M, Chey WD. Editorial: Abnormal Immune Regulation and Low-Grade Inflammation in IBS: Does One Size Fit All? American Journal of Gastroenterology 2012;107:273-5. [DOI: 10.1038/ajg.2011.427] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
156 El-Salhy M, Mazzawi T, Gundersen D, Hausken T. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome. Mol Med Rep 2012;6:1223-5. [PMID: 22992886 DOI: 10.3892/mmr.2012.1087] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
157 Buhner S, Li Q, Vignali S, Barbara G, De Giorgio R, Stanghellini V, Cremon C, Zeller F, Langer R, Daniel H. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology. 2009;137:1425-1434. [PMID: 19596012 DOI: 10.1053/j.gastro.2009.07.005] [Cited by in Crossref: 225] [Cited by in F6Publishing: 213] [Article Influence: 18.8] [Reference Citation Analysis]
158 O’hara JR, Sharkey KA. Proliferative capacity of enterochromaffin cells in guinea-pigs with experimental ileitis. Cell Tissue Res 2007;329:433-41. [DOI: 10.1007/s00441-007-0430-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
159 Ghoshal UC, Ranjan P. Post-infectious irritable bowel syndrome: the past, the present and the future. J Gastroenterol Hepatol. 2011;26 Suppl 3:94-101. [PMID: 21443719 DOI: 10.1111/j.1440-1746.2011.06643.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
160 Lazaridis N, Germanidis G. Current insights into the innate immune system dysfunction in irritable bowel syndrome. Ann Gastroenterol 2018;31:171-87. [PMID: 29507464 DOI: 10.20524/aog.2018.0229] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
161 Bradesi S, Tillisch K, Mayer E. Emerging drugs for irritable bowel syndrome. Expert Opin Emerg Drugs 2006;11:293-313. [PMID: 16634703 DOI: 10.1517/14728214.11.2.293] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
162 Bafutto M, Almeida JR, Leite NV, Costa MB, Oliveira EC, Resende-Filho J. Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii. Arq Gastroenterol. 2013;50:304-309. [PMID: 24474234 DOI: 10.1590/s0004-28032013000400012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
163 Soyturk M, Akpinar H, Gurler O, Pozio E, Sari I, Akar S, Akarsu M, Birlik M, Onen F, Akkoc N. Irritable bowel syndrome in persons who acquired trichinellosis. Am J Gastroenterol. 2007;102:1064-1069. [PMID: 17313500 DOI: 10.1111/j.1572-0241.2007.01084.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
164 Gwee KA, Bak YT, Ghoshal UC, Gonlachanvit S, Lee OY, Fock KM, Chua AS, Lu CL, Goh KL, Kositchaiwat C, Makharia G, Park HJ, Chang FY, Fukudo S, Choi MG, Bhatia S, Ke M, Hou X, Hongo M; Asian Neurogastroenterology and Motility Association. Asian consensus on irritable bowel syndrome. J Gastroenterol Hepatol. 2010;25:1189-1205. [PMID: 20594245 DOI: 10.1111/j.1440-1746.2010.06353.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 99] [Article Influence: 10.3] [Reference Citation Analysis]
165 Pimentel M, Lezcano S. Irritable Bowel Syndrome: Bacterial Overgrowth--What’s Known and What to Do. Curr Treat Options Gastroenterol. 2007;10:328-337. [PMID: 17761126 DOI: 10.1007/s11938-007-0076-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
166 Schmulson M, Bielsa MV, Carmona-Sánchez R, Hernández A, López-Colombo A, López Vidal Y, Peláez-Luna M, Remes-Troche JM, Tamayo JL, Valdovinos MA. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review. Rev Gastroenterol Mex. 2014;79:96-134. [PMID: 24857420 DOI: 10.1016/j.rgmx.2014.01.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
167 El-Salhy M, Mazzawi T, Gundersen D, Hatlebakk JG, Hausken T. The role of peptide YY in gastrointestinal diseases and disorders (review). Int J Mol Med. 2013;31:275-282. [PMID: 23292145 DOI: 10.3892/ijmm.2012.1222] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
168 Spiller R. Serotonin, inflammation, and IBS: fitting the jigsaw together? J Pediatr Gastroenterol Nutr. 2007;45 Suppl 2:S115-S119. [PMID: 18185071 DOI: 10.1097/mpg.0b013e31812e66da] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
169 Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26:535-544. [PMID: 17661757 DOI: 10.1111/j.1365-2036.2007.03399.x] [Cited by in Crossref: 294] [Cited by in F6Publishing: 248] [Article Influence: 21.0] [Reference Citation Analysis]
170 Videlock EJ, Chang L. Latest Insights on the Pathogenesis of Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:505-22. [PMID: 34304785 DOI: 10.1016/j.gtc.2021.04.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am. 2005;34:235-245, vi-vii. [PMID: 15862932 DOI: 10.1016/j.gtc.2005.02.007] [Cited by in Crossref: 125] [Cited by in F6Publishing: 109] [Article Influence: 7.8] [Reference Citation Analysis]
172 Scallan Walter EJ, Crim SM, Bruce BB, Griffin PM. Postinfectious Irritable Bowel Syndrome After Campylobacter Infection. Am J Gastroenterol 2019;114:1649-56. [DOI: 10.14309/ajg.0000000000000408] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
173 Koloski N, Holtmann G, Talley NJ. Is there a causal link between psychological disorders and functional gastrointestinal disorders? Expert Rev Gastroenterol Hepatol 2020;14:1047-59. [PMID: 32715790 DOI: 10.1080/17474124.2020.1801414] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
174 Annaházi A, Gecse K, Dabek M, Ait-Belgnaoui A, Rosztóczy A, Róka R, Molnár T, Theodorou V, Wittmann T, Bueno L. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice. Pain. 2009;144:209-217. [PMID: 19450926 DOI: 10.1016/j.pain.2009.04.017] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 5.2] [Reference Citation Analysis]
175 Ishihara S, Aziz M, Oshima N, Mishima Y, Imaoka H, Moriyama I, Kinoshita Y. Irritable bowel syndrome and inflammatory bowel disease: infectious gastroenteritis-related disorders? Clin J Gastroenterol. 2009;2:9-16. [PMID: 26191801 DOI: 10.1007/s12328-008-0051-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
176 Crooks B, Stamataki NS, McLaughlin JT. Appetite, the enteroendocrine system, gastrointestinal disease and obesity. Proc Nutr Soc 2021;80:50-8. [PMID: 32364087 DOI: 10.1017/S0029665120006965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
177 Cremon C, Pallotti F, Bacchilega M, Stanghellini V, Corinaldesi R, Barbara G. Antiflagellin antibodies suggest infective participation in irritable bowel syndrome pathogenesis. Expert Rev Gastroenterol Hepatol. 2008;2:735-740. [PMID: 19090734 DOI: 10.1586/17474124.2.6.735] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
178 Sarna SK. Lessons Learnt from Post-Infectious IBS. Front Physiol. 2011;2:49. [PMID: 21897820 DOI: 10.3389/fphys.2011.00049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
179 Barratt HS, Kalantzis C, Polymeros D, Forbes A. Functional symptoms in inflammatory bowel disease and their potential influence in misclassification of clinical status. Aliment Pharmacol Ther. 2005;21:141-147. [PMID: 15679763 DOI: 10.1111/j.1365-2036.2005.02314.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
180 Vermeire S, Van Assche G, Rutgeerts P. Postinfectious irritable bowel syndrome: a genetic link identified? Gastroenterology 2010;138:1246-9. [PMID: 20188132 DOI: 10.1053/j.gastro.2010.02.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
181 Koo HL, DuPont HL. Current and future developments in travelers' diarrhea therapy. Expert Rev Anti Infect Ther 2006;4:417-27. [PMID: 16771619 DOI: 10.1586/14787210.4.3.417] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
182 Spiller RC. Irritable bowel syndrome: gender, infection, lifestyle or what else? Dig Dis 2011;29:215-21. [PMID: 21734387 DOI: 10.1159/000323924] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
183 Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Spiller RC. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil. 2007;19:62-88. [PMID: 17280586 DOI: 10.1111/j.1365-2982.2006.00875.x] [Cited by in Crossref: 244] [Cited by in F6Publishing: 230] [Article Influence: 17.4] [Reference Citation Analysis]
184 Tanaka Y, Kanazawa M, Fukudo S, Drossman DA. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:131-139. [PMID: 21602989 DOI: 10.5056/jnm.2011.17.2.131] [Cited by in Crossref: 155] [Cited by in F6Publishing: 113] [Article Influence: 15.5] [Reference Citation Analysis]
185 Grover M, Camilleri M, Smith K, Linden DR, Farrugia G. On the fiftieth anniversary. Postinfectious irritable bowel syndrome: mechanisms related to pathogens. Neurogastroenterol Motil. 2014;26:156-167. [PMID: 24438587 DOI: 10.1111/nmo.12304] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
186 Creed F. Exploding myths about medically unexplained symptoms. J Psychosom Res 2016;85:91-3. [PMID: 26944541 DOI: 10.1016/j.jpsychores.2016.02.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
187 Camilleri M. Editorial: fecal granins in IBS: cause or indicator of intestinal or colonic irritation? Am J Gastroenterol. 2012;107:448-450. [PMID: 22388024 DOI: 10.1038/ajg.2011.465] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
188 Spiller RC. Targeting the 5-HT(3) receptor in the treatment of irritable bowel syndrome. Curr Opin Pharmacol. 2011;11:68-74. [PMID: 21398180 DOI: 10.1016/j.coph.2011.02.005] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
189 Jee SR, Morales W, Low K, Chang C, Zhu A, Pokkunuri V, Chatterjee S, Soffer E, Conklin JL, Pimentel M. ICC density predicts bacterial overgrowth in a rat model of post-infectious IBS. World J Gastroenterol. 2010;16:3680-3686. [PMID: 20677340 DOI: 10.3748/wjg.v16.i29.3680] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
190 Gutiérrez RL, Riddle MS, Porter CK. Increased risk of functional gastrointestinal sequelae after Clostridium difficile infection among active duty United States military personnel (1998-2010). Gastroenterology 2015;149:1408-14. [PMID: 26255560 DOI: 10.1053/j.gastro.2015.07.059] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
191 Pifer R, Sperandio V, Sperandio V, Hovde CJ. The Interplay between the Microbiota and Enterohemorrhagic Escherichia coli. Microbiol Spectr 2014;2. [DOI: 10.1128/microbiolspec.ehec-0015-2013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
192 Berumen A, Lennon R, Breen-Lyles M, Griffith J, Patel R, Boxrud D, Decuir M, Farrugia G, Smith K, Grover M. Characteristics and Risk Factors of Post-Infection Irritable Bowel Syndrome After Campylobacter Enteritis. Clin Gastroenterol Hepatol 2021;19:1855-1863.e1. [PMID: 32711045 DOI: 10.1016/j.cgh.2020.07.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
193 Ghoshal UC, Gwee KA. Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link. Nat Rev Gastroenterol Hepatol. 2017;14:435-441. [PMID: 28513629 DOI: 10.1038/nrgastro.2017.37] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 9.5] [Reference Citation Analysis]
194 Ohman L, Simrén M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis. 2007;39:201-215. [PMID: 17267314 DOI: 10.1016/j.dld.2006.10.014] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 6.9] [Reference Citation Analysis]
195 Aroniadis OC, Drossman DA, Simrén M. A Perspective on Brain–Gut Communication: The American Gastroenterology Association and American Psychosomatic Society Joint Symposium on Brain–Gut Interactions and the Intestinal Microenvironment. Psychosom Med 2017;79:847-56. [DOI: 10.1097/psy.0000000000000431] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 5.3] [Reference Citation Analysis]
196 Janssen R, Krogfelt KA, Cawthraw SA, van Pelt W, Wagenaar JA, Owen RJ. Host-pathogen interactions in Campylobacter infections: the host perspective. Clin Microbiol Rev 2008;21:505-18. [PMID: 18625685 DOI: 10.1128/CMR.00055-07] [Cited by in Crossref: 190] [Cited by in F6Publishing: 93] [Article Influence: 14.6] [Reference Citation Analysis]
197 Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009;136:1979-1988. [PMID: 19457422 DOI: 10.1053/j.gastro.2009.02.074] [Cited by in Crossref: 456] [Cited by in F6Publishing: 392] [Article Influence: 38.0] [Reference Citation Analysis]
198 Al-Khatib K, Lin HC. Immune activation and gut microbes in irritable bowel syndrome. Gut Liver. 2009;3:14-19. [PMID: 20479895 DOI: 10.5009/gnl.2009.3.1.14] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
199 Spreadbury I, Ochoa-cortes F, Ibeakanma C, Martin N, Hurlbut D, Vanner SJ. Concurrent psychological stress and infectious colitis is key to sustaining enhanced peripheral sensory signaling. Neurogastroenterol Motil 2015;27:347-55. [DOI: 10.1111/nmo.12497] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
200 Holtmann G, Shah A, Morrison M. Pathophysiology of Functional Gastrointestinal Disorders: A Holistic Overview. Dig Dis 2017;35 Suppl 1:5-13. [PMID: 29421808 DOI: 10.1159/000485409] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 15.0] [Reference Citation Analysis]
201 McLean PG, Borman RA, Lee K. 5-HT in the enteric nervous system: gut function and neuropharmacology. Trends Neurosci 2007;30:9-13. [PMID: 17126921 DOI: 10.1016/j.tins.2006.11.002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 56] [Article Influence: 4.7] [Reference Citation Analysis]
202 Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology. 2011;140:761-765. [PMID: 21256129 DOI: 10.1053/j.gastro.2011.01.032] [Cited by in Crossref: 122] [Cited by in F6Publishing: 104] [Article Influence: 12.2] [Reference Citation Analysis]
203 Kim HS, Lim JH, Park H, Lee SI. Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection--an observation in a small case control study. Yonsei Med J. 2010;51:45-51. [PMID: 20046513 DOI: 10.3349/ymj.2010.51.1.45] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 4.2] [Reference Citation Analysis]
204 Pensabene L, Talarico V, Concolino D, Ciliberto D, Campanozzi A, Gentile T, Rutigliano V, Salvatore S, Staiano A, Di Lorenzo C, Graziano F, Palermo BV, Sanseviero M, Altomare F, Cozza E, Falvo A, Marseglia A, Gatta E, De Venuto D, Ripepi A, Turco R. Postinfectious Functional Gastrointestinal Disorders in Children: A Multicenter Prospective Study. The Journal of Pediatrics 2015;166:903-907.e1. [DOI: 10.1016/j.jpeds.2014.12.050] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
205 Katiraei P, Bultron G. Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome. World J Gastroenterol. 2011;17:2791-2800. [PMID: 21734786 DOI: 10.3748/wjg.v17.i23.2791] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
206 Rabbi MF, Eissa N, Munyaka PM, Kermarrec L, Elgazzar O, Khafipour E, Bernstein CN, Ghia JE. Reactivation of Intestinal Inflammation Is Suppressed by Catestatin in a Murine Model of Colitis via M1 Macrophages and Not the Gut Microbiota. Front Immunol 2017;8:985. [PMID: 28871257 DOI: 10.3389/fimmu.2017.00985] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
207 Cao YN, Feng LJ, Liu YY, Jiang K, Zhang MJ, Gu YX, Wang BM, Gao J, Wang ZL, Wang YM. Effect of Lactobacillus rhamnosus GG supernatant on serotonin transporter expression in rats with post-infectious irritable bowel syndrome. World J Gastroenterol 2018;24:338-50. [PMID: 29391756 DOI: 10.3748/wjg.v24.i3.338] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
208 Lucas A, Cobelens PM, Kavelaars A, Heijnen CJ, Holtmann G, Haag S, Gerken G, Langhorst J, Dobos GJ, Schedlowski M. Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remission. J Neuroimmunol. 2007;182:195-203. [PMID: 17112600 DOI: 10.1016/j.jneuroim.2006.09.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
209 Holland AM, Bon-Frauches AC, Keszthelyi D, Melotte V, Boesmans W. The enteric nervous system in gastrointestinal disease etiology. Cell Mol Life Sci 2021;78:4713-33. [PMID: 33770200 DOI: 10.1007/s00018-021-03812-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
210 Cheng AC, McDonald JR, Thielman NM. Infectious diarrhea in developed and developing countries. J Clin Gastroenterol 2005;39:757-73. [PMID: 16145337 DOI: 10.1097/01.mcg.0000177231.13770.07] [Cited by in Crossref: 81] [Cited by in F6Publishing: 50] [Article Influence: 5.4] [Reference Citation Analysis]
211 Schwille-Kiuntke J, Enck P, Polster AV, Gaile M, Kremsner PG, Zanger P. Postinfectious irritable bowel syndrome after travelers' diarrhea--a cohort study. Neurogastroenterol Motil 2015;27:1147-55. [PMID: 26009981 DOI: 10.1111/nmo.12601] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
212 Jalanka J, Lam C, Bennett A, Hartikainen A, Crispie F, Finnegan LA, Cotter PD, Spiller R. Colonic Gene Expression and Fecal Microbiota in Diarrhea-predominant Irritable Bowel Syndrome: Increased Toll-like Receptor 4 but Minimal Inflammation and no Response to Mesalazine. J Neurogastroenterol Motil 2021;27:279-91. [PMID: 33795545 DOI: 10.5056/jnm20205] [Reference Citation Analysis]
213 Sadeghi A, Biglari M, Nasseri Moghaddam S. Post-infectious Irritable Bowel Syndrome: A Narrative Review. Middle East J Dig Dis 2019;11:69-75. [PMID: 31380002 DOI: 10.15171/mejdd.2019.130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
214 Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut. 2007;56:1770-1798. [PMID: 17488783 DOI: 10.1136/gut.2007.119446corr1] [Reference Citation Analysis]
215 Barbara G, Grover M, Bercik P, Corsetti M, Ghoshal UC, Ohman L, Rajilić-Stojanović M. Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome. Gastroenterology 2019;156:46-58.e7. [PMID: 30009817 DOI: 10.1053/j.gastro.2018.07.011] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 18.3] [Reference Citation Analysis]
216 Ma X, Wang X, Kang N, Chen T, Ji H, Lv L, Yin X, Tian Y, Zheng R, Duan Y, Wang F, Tang X. The Effect of Tong-Xie-Yao-Fang on Intestinal Mucosal Mast Cells in Postinfectious Irritable Bowel Syndrome Rats. Evid Based Complement Alternat Med. 2017;2017:9086034. [PMID: 28331524 DOI: 10.1155/2017/9086034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
217 El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T. High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis. World J Gastroenterol. 2012;18:6070-6075. [PMID: 23155335 DOI: 10.3748/wjg.v18.i42.6070] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 39] [Article Influence: 6.5] [Reference Citation Analysis]
218 Ratanasirintrawoot S, Israsena N. Stem Cells in the Intestine: Possible Roles in Pathogenesis of Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2016;22:367-382. [PMID: 27184041 DOI: 10.5056/jnm16023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
219 Koh SJ, Lee DH, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Kim N, Im JP, Kim JS, Jung HC. Incidence and risk factors of irritable bowel syndrome in community subjects with culture-proven bacterial gastroenteritis. Korean J Gastroenterol 2012;60:13-8. [PMID: 22832795 DOI: 10.4166/kjg.2012.60.1.13] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
220 Jalanka-tuovinen J, Salojärvi J, Salonen A, Immonen O, Garsed K, Kelly FM, Zaitoun A, Palva A, Spiller RC, de Vos WM. Faecal microbiota composition and host–microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut 2014;63:1737-45. [DOI: 10.1136/gutjnl-2013-305994] [Cited by in Crossref: 180] [Cited by in F6Publishing: 160] [Article Influence: 22.5] [Reference Citation Analysis]
221 Fan W, Ding C, Xu N, Zong S, Ma P, Gu B. Close association between intestinal microbiota and irritable bowel syndrome. Eur J Clin Microbiol Infect Dis 2017;36:2303-17. [DOI: 10.1007/s10096-017-3060-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
222 Zang KH, Shao YY, Zuo X, Rao Z, Qin HY. Oridonin Alleviates Visceral Hyperalgesia in a Rat Model of Postinflammatory Irritable Bowel Syndrome: Role of Colonic Enterochromaffin Cell and Serotonin Availability. J Med Food. 2016;19:586-592. [PMID: 27111743 DOI: 10.1089/jmf.2015.3595] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
223 Qin HY, Wu JC, Tong XD, Sung JJ, Xu HX, Bian ZX. Systematic review of animal models of post-infectious/post-inflammatory irritable bowel syndrome. J Gastroenterol. 2011;46:164-174. [PMID: 20848144 DOI: 10.1007/s00535-010-0321-6] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 5.6] [Reference Citation Analysis]
224 Wadhwa A, Al Nahhas MF, Dierkhising RA, Patel R, Kashyap P, Pardi DS, Khanna S, Grover M. High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection. Aliment Pharmacol Ther 2016;44:576-82. [PMID: 27444134 DOI: 10.1111/apt.13737] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 11.4] [Reference Citation Analysis]
225 Lam C, Tan W, Leighton M, Hastings M, Lingaya M, Falcone Y, Zhou X, Xu L, Whorwell P, Walls AF. A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D). Gut. 2016;65:91-99. [PMID: 25765462 DOI: 10.1136/gutjnl-2015-309122] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 7.7] [Reference Citation Analysis]
226 Blaser MJ, Engberg J. Clinical Aspects of Campylobacter jejuni and Campylobacter coli Infections. In: Nachamkin I, Szymanski CM, Blaser MJ, editors. Campylobacter. Washington: ASM Press; 2008. pp. 97-121. [DOI: 10.1128/9781555815554.ch6] [Cited by in Crossref: 65] [Cited by in F6Publishing: 14] [Article Influence: 9.3] [Reference Citation Analysis]
227 Barbara G, De Giorgio R, Stanghellini V, Cremon C, Salvioli B, Corinaldesi R. New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther. 2004;20 Suppl 2:1-9. [PMID: 15335408 DOI: 10.1111/j.1365-2036.2004.02036.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 120] [Article Influence: 7.1] [Reference Citation Analysis]
228 Nasser Y, Boeckxstaens GE, Wouters MM, Schemann M, Vanner S. Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome. Neurogastroenterol Motil. 2014;26:455-469. [PMID: 24602069 DOI: 10.1111/nmo.12316] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
229 Spiller R, Bennett A. Searching for the Answer to Irritable Bowel Syndrome in the Colonic Mucosa: SERTainty and UnSERTainty. Gastroenterology 2007;132:437-41. [DOI: 10.1053/j.gastro.2006.12.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
230 Quigley EMM. What is the evidence for the use of probiotics in functional disorders? Curr Gastroenterol Rep 2008;10:379-84. [DOI: 10.1007/s11894-008-0072-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
231 El-salhy M, Gundersen D, Hatlebakk JG, Hausken T. Diet and Irritable Bowel Syndrome, with a Focus on Appetite-Regulating Gut Hormones. Nutrition in the Prevention and Treatment of Abdominal Obesity. Elsevier; 2014. pp. 5-16. [DOI: 10.1016/b978-0-12-407869-7.00001-5] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
232 Connor BA. Chronic diarrhea in travelers. Curr Infect Dis Rep 2013;15:203-10. [PMID: 23532349 DOI: 10.1007/s11908-013-0328-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
233 Kaakoush NO, Castaño-Rodríguez N, Mitchell HM, Man SM. Global Epidemiology of Campylobacter Infection. Clin Microbiol Rev 2015;28:687-720. [PMID: 26062576 DOI: 10.1128/CMR.00006-15] [Cited by in Crossref: 602] [Cited by in F6Publishing: 297] [Article Influence: 100.3] [Reference Citation Analysis]
234 Spiller R, Campbell E. Post-infectious irritable bowel syndrome. Curr Opin Gastroenterol. 2006;22:13-17. [PMID: 16319671 DOI: 10.1097/01.mog.0000194792.36466.5c] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 4.5] [Reference Citation Analysis]
235 Matricon J, Meleine M, Gelot A, Piche T, Dapoigny M, Muller E, Ardid D. Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther 2012;36:1009-31. [DOI: 10.1111/apt.12080] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 13.9] [Reference Citation Analysis]
236 van Dijk SD, Hanssen D, Naarding P, Lucassen P, Comijs H, Oude Voshaar R. Big Five personality traits and medically unexplained symptoms in later life. Eur Psychiatry 2016;38:23-30. [PMID: 27611331 DOI: 10.1016/j.eurpsy.2016.05.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
237 Spiller R. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterol Motil. 2007;19 Suppl 2:25-31. [PMID: 17620085 DOI: 10.1111/j.1365-2982.2007.00965.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 84] [Article Influence: 6.4] [Reference Citation Analysis]
238 Card T, Enck P, Barbara G, Boeckxstaens GE, Santos J, Azpiroz F, Mearin F, Aziz Q, Marshall J, Spiller R. Post-infectious IBS: Defining its clinical features and prognosis using an internet-based survey. United European Gastroenterol J 2018;6:1245-53. [PMID: 30288287 DOI: 10.1177/2050640618779923] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
239 Kanazawa M, Palsson OS, van Tilburg MA, Gangarosa LM, Fukudo S, Whitehead WE. Motility response to colonic distention is increased in postinfectious irritable bowel syndrome (PI-IBS). Neurogastroenterol Motil. 2014;26:696-704. [PMID: 24602083 DOI: 10.1111/nmo.12318] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
240 Boeckxstaens GE, Wouters MM. Neuroimmune factors in functional gastrointestinal disorders: A focus on irritable bowel syndrome. Neurogastroenterol Motil. 2017;29. [PMID: 28027594 DOI: 10.1111/nmo.13007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
241 Adam B, Liebregts T, Holtmann G. Mechanisms of Disease: genetics of functional gastrointestinal disorders—searching the genes that matter. Nat Rev Gastroenterol Hepatol 2007;4:102-10. [DOI: 10.1038/ncpgasthep0717] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
242 Bennet SM, Ohman L, Simren M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver. 2015;9:318-331. [PMID: 25918261 DOI: 10.5009/gnl14344] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 15.6] [Reference Citation Analysis]
243 El-Salhy M, Mazzawi T, Gundersen D, Hatlebakk JG, Hausken T. Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report. BMC Res Notes 2013;6:391. [PMID: 24073715 DOI: 10.1186/1756-0500-6-391] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
244 Lacy BE, Oʼshana T. Clinical Pearls for Irritable Bowel Syndrome: Management of the Diarrhea-Predominant Subtype. Gastroenterology Nursing 2014;37:392-405. [DOI: 10.1097/sga.0000000000000056] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
245 mizutani T, akiho H, khan WI, murao H, ogino H, kanayama K, nakamura K, takayanagi R. Persistent gut motor dysfunction in a murine model of T-cell-induced enteropathy. Neurogastroenterology & Motility 2010;22:196-e65. [DOI: 10.1111/j.1365-2982.2009.01396.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
246 David LE, Surdea-Blaga T, Dumitrascu DL. Semiquantitative fecal calprotectin test in postinfectious and non-postinfectious irritable bowel syndrome: cross-sectional study. Sao Paulo Med J 2015;133:343-9. [PMID: 26039537 DOI: 10.1590/1516-3180.2014.8000815] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
247 Kilkens TO, Honig A, van Nieuwenhoven MA, Riedel WJ, Brummer RJ. Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls. Gut. 2004;53:1794-1800. [PMID: 15542517 DOI: 10.1136/gut.2004.041657] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 4.1] [Reference Citation Analysis]
248 Wang SH, Dong L, Luo JY, Gong J, Li L, Lu XL, Han SP. Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol. 2007;13:6041-6047. [PMID: 18023097 DOI: 10.3748/wjg.13.6041] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
249 Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7:163-173. [PMID: 20101257 DOI: 10.1038/nrgastro.2010.4] [Cited by in Crossref: 362] [Cited by in F6Publishing: 318] [Article Influence: 32.9] [Reference Citation Analysis]
250 Quigley EM. The Use of Probiotics in Functional Bowel Disease. Gastroenterology Clinics of North America 2005;34:533-45. [DOI: 10.1016/j.gtc.2005.05.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
251 Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol. 2004;18:641-661. [PMID: 15324705 DOI: 10.1016/j.bpg.2004.04.002] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 4.1] [Reference Citation Analysis]
252 Spiller RC. Potential future therapies for Irritable Bowel Syndrome: Will Disease Modifying Therapy as Opposed to Symptomatic Control Become a Reality? Gastroenterology Clinics of North America 2005;34:337-54. [DOI: 10.1016/j.gtc.2005.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
253 Martin-Viñas JJ, Quigley EM. Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators. J Dig Dis 2016;17:572-81. [PMID: 27426409 DOI: 10.1111/1751-2980.12379] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
254 López-gómez L, Bagüés A, Uranga JA, Abalo R. Preclinical models of irritable bowel syndrome. A Comprehensive Overview of Irritable Bowel Syndrome. Elsevier; 2020. pp. 233-76. [DOI: 10.1016/b978-0-12-821324-7.00012-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
255 Kerckhoffs AP, Ter Linde JJ, Akkermans LM, Samsom M. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients. Neurogastroenterol Motil. 2008;20:900-907. [PMID: 18363639 DOI: 10.1111/j.1365-2982.2008.01100.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 4.8] [Reference Citation Analysis]
256 Brierley S. Altered Ion Channel/Receptor Expression and Function in Extrinsic Sensory Neurons: The Cause of and Solution to Chronic Visceral Pain? Adv Exp Med Biol 2016;891:75-90. [PMID: 27379637 DOI: 10.1007/978-3-319-27592-5_9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
257 Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am. 2005;34:235-245, vi-vii. [PMID: 15862932 DOI: org/10.1016/j.gtc.2005.02.007] [Reference Citation Analysis]
258 Spence MJ, Moss-Morris R. The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis. Gut 2007;56:1066-71. [PMID: 17324974 DOI: 10.1136/gut.2006.108811] [Cited by in Crossref: 97] [Cited by in F6Publishing: 79] [Article Influence: 6.9] [Reference Citation Analysis]
259 Smith JL, Bayles D. Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis. J Food Prot 2007;70:1762-9. [PMID: 17685356 DOI: 10.4315/0362-028x-70.7.1762] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
260 El-Salhy M, Hatlebakk JG, Gilja OH, Hausken T. Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment. Expert Rev Gastroenterol Hepatol. 2014;8:435-443. [PMID: 24580043 DOI: 10.1586/17474124.2014.888952] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
261 Simrén M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, Verdu EF, Whorwell PJ, Zoetendal EG; Rome Foundation Committee. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013;62:159-76. [PMID: 22730468 DOI: 10.1136/gutjnl-2012-302167] [Cited by in Crossref: 513] [Cited by in F6Publishing: 424] [Article Influence: 57.0] [Reference Citation Analysis]
262 Guerry P, Poly F, Riddle M, Maue AC, Chen YH, Monteiro MA. Campylobacter polysaccharide capsules: virulence and vaccines. Front Cell Infect Microbiol 2012;2:7. [PMID: 22919599 DOI: 10.3389/fcimb.2012.00007] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 8.0] [Reference Citation Analysis]
263 Langhorst J, Choi KE. The role of human defensins in gastrointestinal diseases. Expert Rev Clin Immunol. 2011;7:779-787. [PMID: 22014019 DOI: 10.1586/eci.11.62] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
264 Flemström G, Sjöblom M. Epithelial Cells and Their Neighbors. II. New perspectives on efferent signaling between brain, neuroendocrine cells, and gut epithelial cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 2005;289:G377-80. [DOI: 10.1152/ajpgi.00093.2005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
265 Qin HY, Xiao HT, Wu JC, Berman BM, Sung JJ, Bian ZX. Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats. World J Gastroenterol. 2012;18:2481-2492. [PMID: 22654445 DOI: 10.3748/wjg.v18.i20.2481] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
266 Hadjivasilis A, Tsioutis C, Michalinos A, Ntourakis D, Christodoulou DK, Agouridis AP. New insights into irritable bowel syndrome: from pathophysiology to treatment. Ann Gastroenterol 2019;32:554-64. [PMID: 31700231 DOI: 10.20524/aog.2019.0428] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
267 Bertani E, Ravizza D, Milione M, Massironi S, Grana CM, Zerini D, Piccioli AN, Spinoglio G, Fazio N. Neuroendocrine neoplasms of rectum: A management update. Cancer Treat Rev. 2018;66:45-55. [PMID: 29684743 DOI: 10.1016/j.ctrv.2018.04.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
268 Vermeulen W, De Man JG, Pelckmans PA, De Winter BY. Neuroanatomy of lower gastrointestinal pain disorders. World J Gastroenterol. 2014;20:1005-1020. [PMID: 24574773 DOI: 10.3748/wjg.v20.i4.1005] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 46] [Article Influence: 8.7] [Reference Citation Analysis]
269 Quigley EM. Changing face of irritable bowel syndrome. World J Gastroenterol 2006;12:1-5. [PMID: 16440408 DOI: 10.3748/wjg.v12.i1.1] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
270 Saps M, Pensabene L, Di Martino L, Staiano A, Wechsler J, Zheng X, Di Lorenzo C. Post-infectious functional gastrointestinal disorders in children. J Pediatr. 2008;152:812-816, 816.e1. [PMID: 18492522 DOI: 10.1016/j.jpeds.2007.11.042] [Cited by in Crossref: 99] [Cited by in F6Publishing: 69] [Article Influence: 7.6] [Reference Citation Analysis]
271 Schneck AS, Anty R, Tran A, Hastier A, Amor IB, Gugenheim J, Iannelli A, Piche T. Increased Prevalence of Irritable Bowel Syndrome in a Cohort of French Morbidly Obese Patients Candidate for Bariatric Surgery. Obes Surg. 2016;26:1525-1530. [PMID: 26424705 DOI: 10.1007/s11695-015-1907-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
272 Rinttilä T, Lyra A, Krogius-Kurikka L, Palva A. Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects. Gut Pathog. 2011;3:6. [PMID: 21518462 DOI: 10.1186/1757-4749-3-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
273 Humes DJ, Simpson J, Neal KR, Scholefield JH, Spiller RC. Psychological and colonic factors in painful diverticulosis. Br J Surg. 2008;95:195-198. [PMID: 17939130 DOI: 10.1002/bjs.5962] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
274 Thabane M, Marshall JK. Post-infectious irritable bowel syndrome. World J Gastroenterol. 2009;15:3591-3596. [PMID: 19653335 DOI: 10.3748/wjg.15.3591] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 79] [Article Influence: 7.2] [Reference Citation Analysis]
275 Quigley EM. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management. J Dig Dis. 2007;8:2-7. [PMID: 17261128 DOI: 10.1111/j.1443-9573.2007.00277.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
276 Akbar A, Yiangou Y, Facer P, Walters JR, Anand P, Ghosh S. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut. 2008;57:923-929. [PMID: 18252749 DOI: 10.1136/gut.2007.138982] [Cited by in Crossref: 316] [Cited by in F6Publishing: 275] [Article Influence: 24.3] [Reference Citation Analysis]
277 Keating C, Beyak M, Foley S, Singh G, Marsden C, Spiller R, Grundy D. Afferent hypersensitivity in a mouse model of post-inflammatory gut dysfunction: role of altered serotonin metabolism. J Physiol. 2008;586:4517-4530. [PMID: 18653657 DOI: 10.1113/jphysiol.2008.156984] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 5.1] [Reference Citation Analysis]
278 Sobel RM, Markov D. The impact of anxiety and mood disorders on physical disease: The worried not-so-well. Curr Psychiatry Rep 2005;7:206-12. [DOI: 10.1007/s11920-005-0055-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
279 Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol. 2010;1:97-105. [PMID: 21607147 DOI: 10.4291/wjgp.v1.i3.97] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 52] [Article Influence: 5.4] [Reference Citation Analysis]
280 Lewis JH. Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective. Expert Review of Gastroenterology & Hepatology 2014;4:13-29. [DOI: 10.1586/egh.09.72] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
281 El-Salhy M, Gilja OH, Gundersen D, Hatlebakk JG, Hausken T. Endocrine cells in the ileum of patients with irritable bowel syndrome. World J Gastroenterol 2014;20:2383-91. [PMID: 24605036 DOI: 10.3748/wjg.v20.i9.2383] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
282 Youn YH, Kim HC, Lim HC, Park JJ, Kim JH, Park H. Long-term Clinical Course of Post-infectious Irritable Bowel Syndrome After Shigellosis: A 10-year Follow-up Study. J Neurogastroenterol Motil 2016;22:490-6. [PMID: 26908484 DOI: 10.5056/jnm15157] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
283 Kindt S, Tertychnyy A, de Hertogh G, Geboes K, Tack J. Intestinal immune activation in presumed post-infectious functional dyspepsia. Neurogastroenterol Motil. 2009;21:832-e56. [PMID: 19460107 DOI: 10.1111/j.1365-2982.2009.01299.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 6.3] [Reference Citation Analysis]
284 Feng CC, Yan XJ, Chen X, Wang EM, Liu Q, Zhang LY, Chen J, Fang JY, Chen SL. Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats. Pain 2014;155:1591-604. [PMID: 24813296 DOI: 10.1016/j.pain.2014.05.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
285 Quigley EM, Abdel-Hamid H, Barbara G, Bhatia SJ, Boeckxstaens G, De Giorgio R, Delvaux M, Drossman DA, Foxx-Orenstein AE, Guarner F. A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on Irritable Bowel Syndrome. J Clin Gastroenterol. 2012;46:356-366. [PMID: 22499071 DOI: 10.1097/mcg.0b013e318247157c] [Cited by in Crossref: 95] [Cited by in F6Publishing: 35] [Article Influence: 10.6] [Reference Citation Analysis]
286 El-Salhy M, Gilja OH, Gundersen D, Hausken T. Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome. World J Gastrointest Endosc. 2014;6:176-185. [PMID: 24891930 DOI: 10.4253/wjge.v6.i5.176] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
287 Keithlin J, Sargeant J, Thomas MK, Fazil A. Systematic review and meta-analysis of the proportion of Campylobacter cases that develop chronic sequelae. BMC Public Health 2014;14:1203. [PMID: 25416162 DOI: 10.1186/1471-2458-14-1203] [Cited by in Crossref: 75] [Cited by in F6Publishing: 51] [Article Influence: 10.7] [Reference Citation Analysis]
288 Wang Y, Jiang R, Wu Z, Zhou L, Xu J, Huang C, Yang L, Zhu B, Yan E, Liu C, Yang C. Gut microbiota is involved in the antidepressant-like effect of (S)-norketamine in an inflammation model of depression. Pharmacol Biochem Behav 2021;207:173226. [PMID: 34217782 DOI: 10.1016/j.pbb.2021.173226] [Reference Citation Analysis]
289 Sikander A, Rana SV, Prasad KK. Role of serotonin in gastrointestinal motility and irritable bowel syndrome. Clinica Chimica Acta 2009;403:47-55. [DOI: 10.1016/j.cca.2009.01.028] [Cited by in Crossref: 135] [Cited by in F6Publishing: 116] [Article Influence: 11.3] [Reference Citation Analysis]
290 Kirsch R, Riddell RH. Histopathological alterations in irritable bowel syndrome. Mod Pathol. 2006;19:1638-1645. [PMID: 17013373 DOI: 10.1038/modpathol.3800704] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
291 El-Salhy M, Gundersen D. Diet in irritable bowel syndrome. Nutr J. 2015;14:36. [PMID: 25880820 DOI: 10.1186/s12937-015-0022-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
292 Soares RL. Irritable bowel syndrome: a clinical review. World J Gastroenterol. 2014;20:12144-12160. [PMID: 25232249 DOI: 10.3748/wjg.v20.i34.12144] [Cited by in CrossRef: 90] [Cited by in F6Publishing: 72] [Article Influence: 15.0] [Reference Citation Analysis]
293 Wang L, Martínez V, Kimura H, Taché Y. 5-Hydroxytryptophan activates colonic myenteric neurons and propulsive motor function through 5-HT4 receptors in conscious mice. Am J Physiol Gastrointest Liver Physiol 2007;292:G419-28. [PMID: 16990446 DOI: 10.1152/ajpgi.00289.2006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
294 Steiger E. Dysfunction and Thrombotic Complications of Vascular Access Devices. JPEN J Parenter Enteral Nutr 2006;30:S70-2. [DOI: 10.1177/01486071060300s1s70] [Cited by in Crossref: 17] [Article Influence: 1.1] [Reference Citation Analysis]
295 Asproudis I, Tsoumani AT, Katsanos KH, Katsanos AH, Theopistos V, Paschidis KA, Tsianos EV, Christodoulou D. Irritable bowel syndrome might be associated with dry eye disease. Ann Gastroenterol 2016;29:487-91. [PMID: 27708515 DOI: 10.20524/aog.2016.0064] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
296 Khan WI, Ghia JE. Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol. 2010;161:19-27. [PMID: 20408856 DOI: 10.1111/j.1365-2249.2010.04150.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 73] [Article Influence: 2.7] [Reference Citation Analysis]
297 Heitkemper MM, Chang L. Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? Gend Med. 2009;6 Suppl 2:152-167. [PMID: 19406367 DOI: 10.1016/j.genm.2009.03.004] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 6.9] [Reference Citation Analysis]
298 Wang SH, Dong L, Luo JY, Gong J, Li L, Lu XL, Han SP. Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol. 2007;13:6041-6047. [PMID: 18023097 DOI: 10.3748/wjg.v13.45.6041] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 45] [Article Influence: 2.0] [Reference Citation Analysis]
299 Bayer SB, Gearry RB, Drummond LN. Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function. Crit Rev Food Sci Nutr 2018;58:2432-52. [PMID: 28557573 DOI: 10.1080/10408398.2017.1327841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
300 Róka R, Ait-Belgnaoui A, Salvador-Cartier C, Garcia-Villar R, Fioramonti J, Eutamène H, Bueno L. Dexamethasone prevents visceral hyperalgesia but not colonic permeability increase induced by luminal protease-activated receptor-2 agonist in rats. Gut. 2007;56:1072-1078. [PMID: 17309885 DOI: 10.1136/gut.2006.115352] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
301 Rodríguez-Fandiño O, Hernández-Ruiz J, Schmulson M. From cytokines to toll-like receptors and beyond - current knowledge and future research needs in irritable bowel syndrome. J Neurogastroenterol Motil 2010;16:363-73. [PMID: 21103418 DOI: 10.5056/jnm.2010.16.4.363] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
302 Pokkunuri V, Pimentel M, Morales W, Jee SR, Alpern J, Weitsman S, Marsh Z, Low K, Hwang L, Khoshini R. Role of Cytolethal Distending Toxin in Altered Stool Form and Bowel Phenotypes in a Rat Model of Post-infectious Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2012;18:434-442. [PMID: 23106005 DOI: 10.5056/jnm.2012.18.4.434] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
303 Buckley MM, O'Mahony SM, O'Malley D. Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome. World J Gastroenterol. 2014;20:8846-8858. [PMID: 25083058 DOI: 10.3748/wjg.v20.i27.8846] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
304 El-Salhy M, Gundersen D, Gilja OH, Hatlebakk JG, Hausken T. Is irritable bowel syndrome an organic disorder? World J Gastroenterol. 2014;20:384-400. [PMID: 24574708 DOI: 10.3748/wjg.v20.i2.384] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 52] [Article Influence: 9.1] [Reference Citation Analysis]
305 Galligan JJ, Vanner S. Basic and clinical pharmacology of new motility promoting agents. Neurogastroenterol Motil. 2005;17:643-653. [PMID: 16185302 DOI: 10.1111/j.1365-2982.2005.00675.x] [Cited by in Crossref: 101] [Cited by in F6Publishing: 75] [Article Influence: 6.3] [Reference Citation Analysis]
306 Lee YJ, Park KS. Irritable bowel syndrome: emerging paradigm in pathophysiology. World J Gastroenterol 2014;20:2456-69. [PMID: 24627583 DOI: 10.3748/wjg.v20.i10.2456] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 55] [Article Influence: 12.8] [Reference Citation Analysis]
307 Nielsen HL, Engberg J, Ejlertsen T, Nielsen H. Psychometric scores and persistence of irritable bowel after Campylobacter concisus infection. Scand J Gastroenterol 2014;49:545-51. [PMID: 24646319 DOI: 10.3109/00365521.2014.886718] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
308 Singh P, Lembo A. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:523-45. [PMID: 34304786 DOI: 10.1016/j.gtc.2021.03.003] [Reference Citation Analysis]
309 Han CJ, Yang GS. Fatigue in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis of Pooled Frequency and Severity of Fatigue. Asian Nurs Res (Korean Soc Nurs Sci) 2016;10:1-10. [PMID: 27021828 DOI: 10.1016/j.anr.2016.01.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
310 Florens MV, Van Wanrooy S, Dooley J, Aguilera-Lizarraga J, Vanbrabant W, Wouters MM, Van Oudenhove L, Peetermans WE, Liston A, Boeckxstaens GE. Prospective study evaluating immune-mediated mechanisms and predisposing factors underlying persistent postinfectious abdominal complaints. Neurogastroenterol Motil 2019;31:e13542. [PMID: 30657233 DOI: 10.1111/nmo.13542] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
311 Kiefte-de Jong JC, Saridjan NS, Escher JC, Jaddoe VW, Hofman A, Tiemeier H, Moll HA. Cortisol diurnal rhythm and stress reactivity in constipation and abdominal pain: the Generation R Study. J Pediatr Gastroenterol Nutr. 2011;53:394-400. [PMID: 21505363 DOI: 10.1097/mpg.0b013e31821e73cf] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
312 Wang Y, Gong H, Lopez R, Lian L, Kiran RP, Soffer EE, Shen B. Correlation between serum serotonin and endoscopy inflammation scores in patients with ileal pouches. Journal of Crohn's and Colitis 2013;7:e133-42. [DOI: 10.1016/j.crohns.2012.07.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
313 Swan C, Duroudier NP, Campbell E, Zaitoun A, Hastings M, Dukes GE, Cox J, Kelly FM, Wilde J, Lennon MG. Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα. Gut. 2013;62:985-994. [PMID: 22684480 DOI: 10.1136/gutjnl-2011-301213] [Cited by in Crossref: 105] [Cited by in F6Publishing: 94] [Article Influence: 11.7] [Reference Citation Analysis]
314 Mearin F, Perelló A, Balboa A. [Irritable bowel syndrome and inflammatory bowel disease: Is there a connection?]. Gastroenterol Hepatol. 2009;32:364-372. [PMID: 19442413 DOI: 10.1016/j.gastrohep.2008.12.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
315 El-Salhy M, Gilja OH, Hausken T. Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome. Mol Med Rep. 2014;10:1753-1757. [PMID: 25109259 DOI: 10.3892/mmr.2014.2472] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
316 Spiller R, Lam C. An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil. 2012;18:258-268. [PMID: 22837873 DOI: 10.5056/jnm.2012.18.3.258] [Cited by in Crossref: 98] [Cited by in F6Publishing: 87] [Article Influence: 10.9] [Reference Citation Analysis]
317 El-Salhy M, Vaali K, Dizdar V, Hausken T. Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome. Dig Dis Sci. 2010;55:3508-3513. [PMID: 20300845 DOI: 10.1007/s10620-010-1169-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
318 Shajib MS, Baranov A, Khan WI. Diverse Effects of Gut-Derived Serotonin in Intestinal Inflammation. ACS Chem Neurosci 2017;8:920-31. [DOI: 10.1021/acschemneuro.6b00414] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
319 Pimentel M, Chatterjee S, Chang C, Low K, Song Y, Liu C, Morales W, Ali L, Lezcano S, Conklin J, Finegold S. A new rat model links two contemporary theories in irritable bowel syndrome. Dig Dis Sci. 2008;53:982-989. [PMID: 17934822 DOI: 10.1007/s10620-007-9977-z] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
320 Dupont AW. Post-infectious irritable bowel syndrome. Curr Gastroenterol Rep. 2007;9:378-384. [PMID: 17991338 DOI: 10.1007/s11894-007-0046-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
321 Akiho H, Tokita Y, Nakamura K, Satoh K, Nishiyama M, Tsuchiya N, Tsuchiya K, Ohbuchi K, Iwakura Y, Ihara E, Takayanagi R, Yamamoto M. Involvement of interleukin-17A-induced hypercontractility of intestinal smooth muscle cells in persistent gut motor dysfunction. PLoS One 2014;9:e92960. [PMID: 24796324 DOI: 10.1371/journal.pone.0092960] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
322 Solcia E, Vanoli A. Histogenesis and Natural History of Gut Neuroendocrine Tumors: Present Status. Endocr Pathol 2014;25:165-70. [DOI: 10.1007/s12022-014-9312-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
323 Spiller RC. Potential biomarkers. Gastroenterol Clin North Am. 2011;40:121-139. [PMID: 21333904 DOI: 10.1016/j.gtc.2011.01.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
324 Kennedy PJ, Cryan JF, Dinan TG, Clarke G. Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol 2014;20:14105-25. [PMID: 25339800 DOI: 10.3748/wjg.v20.i39.14105] [Cited by in CrossRef: 175] [Cited by in F6Publishing: 136] [Article Influence: 29.2] [Reference Citation Analysis]
325 Grover M, Dorn SD, Weinland SR, Dalton CB, Gaynes BN, Drossman DA. Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders. Dig Dis Sci 2009;54:1284-91. [PMID: 19242800 DOI: 10.1007/s10620-009-0723-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
326 Videlock EJ, Chang L. Irritable bowel syndrome: current approach to symptoms, evaluation, and treatment. Gastroenterol Clin North Am. 2007;36:665-685, x. [PMID: 17950443 DOI: 10.1016/j.gtc.2007.07.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
327 Holtmann GJ, Ford AC, Talley NJ. Pathophysiology of irritable bowel syndrome. The Lancet Gastroenterology & Hepatology 2016;1:133-46. [DOI: 10.1016/s2468-1253(16)30023-1] [Cited by in Crossref: 171] [Cited by in F6Publishing: 62] [Article Influence: 34.2] [Reference Citation Analysis]
328 Gunn D, Garsed K, Lam C, Singh G, Lingaya M, Wahl V, Niesler B, Henry A, Hall IP, Whorwell P, Spiller R. Abnormalities of mucosal serotonin metabolism and 5-HT3 receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron. Aliment Pharmacol Ther. 2019;50:538-546. [PMID: 31342534 DOI: 10.1111/apt.15420] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
329 Borgaonkar MR, Ford DC, Marshall JK, Churchill E, Collins SM. The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection. Dig Dis Sci. 2006;51:1026-1032. [PMID: 16758307 DOI: 10.1007/s10620-006-9348-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
330 Qin H, Zang K, Zuo X, Wu X, Bian Z. Quercetin Attenuates Visceral Hypersensitivity and 5-Hydroxytryptamine Availability in Postinflammatory Irritable Bowel Syndrome Rats: Role of Enterochromaffin Cells in the Colon. Journal of Medicinal Food 2019;22:663-71. [DOI: 10.1089/jmf.2018.4264] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
331 Brandt LJ, Aroniadis OC. An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointest Endosc. 2013;78:240-249. [PMID: 23642791 DOI: 10.1016/j.gie.2013.03.1329] [Cited by in Crossref: 141] [Cited by in F6Publishing: 106] [Article Influence: 17.6] [Reference Citation Analysis]
332 Hauser G, Tkalcic M, Pletikosic S, Grabar N, Stimac D. Erythrocyte sedimentation rate - possible role in determining the existence of the low grade inflammation in Irritable Bowel Syndrome patients. Med Hypotheses. 2012;78:818-820. [PMID: 22513237 DOI: 10.1016/j.mehy.2012.03.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
333 Talley NJ. Genes and environment in irritable bowel syndrome: one step forward. Gut 2006;55:1694-6. [PMID: 17124153 DOI: 10.1136/gut.2006.108837] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
334 Nagakura Y, Ohsaka N, Azuma R, Takahashi S, Takebayashi Y, Kawasaki S, Murai S, Miwa M, Saito H. Monoamine system disruption induces functional somatic syndromes associated symptomatology in mice. Physiology & Behavior 2018;194:505-14. [DOI: 10.1016/j.physbeh.2018.07.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
335 Choi K, Chen J, Mitra S, Sarna SK. Impaired integrity of DNA after recovery from inflammation causes persistent dysfunction of colonic smooth muscle. Gastroenterology. 2011;141:1293-1301, 1301.e1-3. [PMID: 21745450 DOI: 10.1053/j.gastro.2011.06.074] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
336 Grover M, Herfarth H, Drossman DA. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome. Clin Gastroenterol Hepatol. 2009;7:48-53. [PMID: 18848909 DOI: 10.1016/j.cgh.2008.08.032] [Cited by in Crossref: 81] [Cited by in F6Publishing: 66] [Article Influence: 6.2] [Reference Citation Analysis]
337 Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol. 2004;18:641-661. [PMID: 15324705 DOI: org/10.1016/j.bpg.2004.04.002] [Reference Citation Analysis]
338 Tillisch K, Chang L. Diagnosis and treatment of irritable bowel syndrome: State of the art. Curr Gastroenterol Rep 2005;7:249-56. [DOI: 10.1007/s11894-005-0016-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
339 Annaházi A, Róka R, Rosztóczy A, Wittmann T. Role of antispasmodics in the treatment of irritable bowel syndrome. World J Gastroenterol 2014;20:6031-43. [PMID: 24876726 DOI: 10.3748/wjg.v20.i20.6031] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
340 Drossman DA. What does the future hold for irritable bowel syndrome and the functional gastrointestinal disorders? J Clin Gastroenterol 2005;39:S251-6. [PMID: 15798493 DOI: 10.1097/01.mcg.0000156107.13247.69] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
341 Vogt L, Meyer D, Pullens G, Faas M, Smelt M, Venema K, Ramasamy U, Schols HA, De Vos P. Immunological Properties of Inulin-Type Fructans. Critical Reviews in Food Science and Nutrition 2014;55:414-36. [DOI: 10.1080/10408398.2012.656772] [Cited by in Crossref: 102] [Cited by in F6Publishing: 79] [Article Influence: 14.6] [Reference Citation Analysis]
342 Li X, Chen H, Lu H, Li W, Chen X, Peng Y, Ge Z. The study on the role of inflammatory cells and mediators in post-infectious functional dyspepsia. Scand J Gastroenterol. 2010;45:573-581. [PMID: 20163288 DOI: 10.3109/00365521003632576] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
343 Leighton MP, Lam C, Mehta S, Spiller RC. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial. Trials. 2013;14:10. [PMID: 23302220 DOI: 10.1186/1745-6215-14-10] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
344 Morcos A, Dinan T, Quigley EM. Irritable bowel syndrome: role of food in pathogenesis and management. J Dig Dis. 2009;10:237-246. [PMID: 19906102 DOI: 10.1111/j.1751-2980.2009.00392.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
345 Mørch K, Hanevik K, Rortveit G, Wensaas KA, Eide GE, Hausken T, Langeland N. Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after. BMC Infect Dis. 2009;9:206. [PMID: 20003489 DOI: 10.1186/1471-2334-9-206] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
346 Hughes PA, Zola H, Penttila IA, Blackshaw LA, Andrews JM, Krumbiegel D. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms? Am J Gastroenterol. 2013;108:1066-1074. [PMID: 23649183 DOI: 10.1038/ajg.2013.120] [Cited by in Crossref: 97] [Cited by in F6Publishing: 79] [Article Influence: 12.1] [Reference Citation Analysis]
347 Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132:397-414. [PMID: 17241888 DOI: 10.1053/j.gastro.2006.11.002] [Cited by in Crossref: 852] [Cited by in F6Publishing: 729] [Article Influence: 60.9] [Reference Citation Analysis]
348 Shariati A, Fallah F, Pormohammad A, Taghipour A, Safari H, Chirani AS, Sabour S, Alizadeh-Sani M, Azimi T. The possible role of bacteria, viruses, and parasites in initiation and exacerbation of irritable bowel syndrome. J Cell Physiol 2019;234:8550-69. [PMID: 30480810 DOI: 10.1002/jcp.27828] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 8.7] [Reference Citation Analysis]
349 Quigley EM, Flourie B. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil. 2007;19:166-172. [PMID: 17300285 DOI: 10.1111/j.1365-2982.2006.00879.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 77] [Article Influence: 6.6] [Reference Citation Analysis]
350 Hasler WL, Parkman HP, Wilson LA, Pasricha PJ, Koch KL, Abell TL, Snape WJ, Farrugia G, Lee L, Tonascia J. Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis. Am J Gastroenterol. 2010;105:2357-2367. [PMID: 20588262 DOI: 10.1038/ajg.2010.253] [Cited by in Crossref: 81] [Cited by in F6Publishing: 58] [Article Influence: 7.4] [Reference Citation Analysis]
351 Ringel Y, Quigley EM, Lin HC. Using Probiotics in Gastrointestinal Disorders. Am J Gastroenterol Suppl 2012;1:34-40. [DOI: 10.1038/ajgsup.2012.7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 19] [Article Influence: 4.9] [Reference Citation Analysis]
352 El-Salhy M, Hausken T, Gilja OH, Hatlebakk JG. The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2017;11:139-148. [PMID: 27927062 DOI: 10.1080/17474124.2017.1269601] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
353 Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol. 2010;1:97-105. [PMID: 21607147 DOI: 10.4291/wjgp.v1.i3.97.] [Reference Citation Analysis]
354 Drossman DA. Psychosocial Factors and the Disorders of GI Function: What is the Link? Am J Gastroenterol 2004;99:358-60. [DOI: 10.1111/j.1572-0241.2004.04076.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
355 Keszthelyi D, Troost F, Simrén M, Ludidi S, Kruimel J, Conchillo J, Masclee A. Revisiting concepts of visceral nociception in irritable bowel syndrome: Visceronociception in irritable bowel syndrome. EJP 2012;16:1444-54. [DOI: 10.1002/j.1532-2149.2012.00147.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
356 O'Hara JR, Skinn AC, MacNaughton WK, Sherman PM, Sharkey KA. Consequences of Citrobacter rodentium infection on enteroendocrine cells and the enteric nervous system in the mouse colon. Cell Microbiol 2006;8:646-60. [PMID: 16548890 DOI: 10.1111/j.1462-5822.2005.00657.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
357 O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128:541-551. [PMID: 15765388 DOI: 10.1053/j.gastro.2004.11.050] [Cited by in Crossref: 923] [Cited by in F6Publishing: 777] [Article Influence: 57.7] [Reference Citation Analysis]
358 Quigley EM. Do Patients with Functional Gastrointestinal Disorders have an Altered Gut Flora? Therap Adv Gastroenterol. 2009;2:23-30. [PMID: 21180551 DOI: 10.1177/1756283X09335636] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
359 Choi Y, Sung T, Kim H, La J, Kim T, Yang I. Increased 5-Hydroxytryptamine Mediates Post-Inflammatory Visceral Hypersensitivity via the 5-Hydroxytryptamine 3 Receptor in Rats. Dig Dis Sci 2008;53:2909-16. [DOI: 10.1007/s10620-008-0244-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
360 Quigley EM. Bacteria: a new player in gastrointestinal motility disorders--infections, bacterial overgrowth, and probiotics. Gastroenterol Clin North Am 2007;36:735-48, xi. [PMID: 17950446 DOI: 10.1016/j.gtc.2007.07.012] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
361 Quigley EM. Probiotics in irritable bowel syndrome: an immunomodulatory strategy? J Am Coll Nutr. 2007;26:684S-690S. [PMID: 18187434 DOI: 10.1080/07315724.2007.10719648] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
362 Sperber AD, Morris CB, Greemberg L, Bangdiwala SI, Goldstein D, Sheiner E, Rusabrov Y, Hu Y, Katz M, Freud T. Development of abdominal pain and IBS following gynecological surgery: a prospective, controlled study. Gastroenterology. 2008;134:75-84. [PMID: 18166349 DOI: 10.1053/j.gastro.2007.10.041] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
363 Hun L. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS. Postgrad Med. 2009;121:119-124. [PMID: 19332970 DOI: 10.3810/pgm.2009.03.1984] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
364 Minderhoud IM, Oldenburg B, Schipper ME, ter Linde JJ, Samsom M. Serotonin synthesis and uptake in symptomatic patients with Crohn’s disease in remission. Clin Gastroenterol Hepatol. 2007;5:714-720. [PMID: 17481962 DOI: 10.1016/j.cgh.2007.02.013] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
365 Chang L. Neuroendocrine and neuroimmune markers in IBS: pathophysiological role or epiphenomenon. Gastroenterology. 2006;130:596-600. [PMID: 16472611 DOI: 10.1053/j.gastro.2005.12.047] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
366 Gloro R, Ducrotte P, Reimund JM. Protease-activated receptors: potential therapeutic targets in irritable bowel syndrome? Expert Opin Ther Targets 2005;9:1079-95. [PMID: 16185159 DOI: 10.1517/14728222.9.5.1079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
367 Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. Journal of Gastroenterology and Hepatology 2008;23:1689-94. [DOI: 10.1111/j.1440-1746.2008.05574.x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 108] [Article Influence: 8.6] [Reference Citation Analysis]
368 Mearin F, Perez-Oliveras M, Perello A, Vinyet J, Ibanez A, Coderch J, Perona M. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology. 2005;129:98-104. [PMID: 16012939 DOI: 10.1053/j.gastro.2005.04.012] [Cited by in Crossref: 270] [Cited by in F6Publishing: 223] [Article Influence: 16.9] [Reference Citation Analysis]
369 Buret AG. How stress induces intestinal hypersensitivity. Am J Pathol 2006;168:3-5. [PMID: 16400003 DOI: 10.2353/ajpath.2006.050958] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]